'en:increased igm levels, polyclonal'
(id=9092676 ; fe=en:increased igm levels, polyclonal ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=16640 creation date=2017-10-27 touchdate=2025-12-02 05:16:45.000) ≈ 788 relations sortantes
- en:increased igm levels, polyclonal --
r_associated #0: 43 / 1 ->
en:candidiasis, chronic mucocutaneous
n1=en:increased igm levels, polyclonal | n2=en:candidiasis, chronic mucocutaneous | rel=r_associated | relid=0 | w=43
- en:increased igm levels, polyclonal --
r_associated #0: 43 / 1 ->
en:cytokine defects
n1=en:increased igm levels, polyclonal | n2=en:cytokine defects | rel=r_associated | relid=0 | w=43
- en:increased igm levels, polyclonal --
r_associated #0: 43 / 1 ->
en:decreased t cell activation
n1=en:increased igm levels, polyclonal | n2=en:decreased t cell activation | rel=r_associated | relid=0 | w=43
- en:increased igm levels, polyclonal --
r_associated #0: 43 / 1 ->
en:hyperglobulinemia, polyclonal (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:hyperglobulinemia, polyclonal (in some patients) | rel=r_associated | relid=0 | w=43
- en:increased igm levels, polyclonal --
r_associated #0: 43 / 1 ->
en:increase in certain cytokines (il4, il5, il13, il17) upon stimulation
n1=en:increased igm levels, polyclonal | n2=en:increase in certain cytokines (il4, il5, il13, il17) upon stimulation | rel=r_associated | relid=0 | w=43
- en:increased igm levels, polyclonal --
r_associated #0: 43 / 1 ->
en:increased serum ige (1 patient)
n1=en:increased igm levels, polyclonal | n2=en:increased serum ige (1 patient) | rel=r_associated | relid=0 | w=43
- en:increased igm levels, polyclonal --
r_associated #0: 43 / 1 ->
en:marked depletion of lymphoid tissues
n1=en:increased igm levels, polyclonal | n2=en:marked depletion of lymphoid tissues | rel=r_associated | relid=0 | w=43
- en:increased igm levels, polyclonal --
r_associated #0: 43 / 1 ->
en:markedly elevated iga
n1=en:increased igm levels, polyclonal | n2=en:markedly elevated iga | rel=r_associated | relid=0 | w=43
- en:increased igm levels, polyclonal --
r_associated #0: 43 / 1 ->
en:microorganism immunology
n1=en:increased igm levels, polyclonal | n2=en:microorganism immunology | rel=r_associated | relid=0 | w=43
- en:increased igm levels, polyclonal --
r_associated #0: 42 / 0.977 ->
en:hemolytic anemia (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:hemolytic anemia (in some patients) | rel=r_associated | relid=0 | w=42
- en:increased igm levels, polyclonal --
r_associated #0: 42 / 0.977 ->
en:igg, decreased
n1=en:increased igm levels, polyclonal | n2=en:igg, decreased | rel=r_associated | relid=0 | w=42
- en:increased igm levels, polyclonal --
r_associated #0: 42 / 0.977 ->
en:immunology, other
n1=en:increased igm levels, polyclonal | n2=en:immunology, other | rel=r_associated | relid=0 | w=42
- en:increased igm levels, polyclonal --
r_associated #0: 42 / 0.977 ->
en:small lymph nodes
n1=en:increased igm levels, polyclonal | n2=en:small lymph nodes | rel=r_associated | relid=0 | w=42
- en:increased igm levels, polyclonal --
r_associated #0: 41 / 0.953 ->
en:childhood-onset systemic lupus erythematosus
n1=en:increased igm levels, polyclonal | n2=en:childhood-onset systemic lupus erythematosus | rel=r_associated | relid=0 | w=41
- en:increased igm levels, polyclonal --
r_associated #0: 41 / 0.953 ->
en:decreased t-cell proliferative responses in vitro
n1=en:increased igm levels, polyclonal | n2=en:decreased t-cell proliferative responses in vitro | rel=r_associated | relid=0 | w=41
- en:increased igm levels, polyclonal --
r_associated #0: 41 / 0.953 ->
en:disseminated candidiasis
n1=en:increased igm levels, polyclonal | n2=en:disseminated candidiasis | rel=r_associated | relid=0 | w=41
- en:increased igm levels, polyclonal --
r_associated #0: 41 / 0.953 ->
en:markedly reduced t cell function
n1=en:increased igm levels, polyclonal | n2=en:markedly reduced t cell function | rel=r_associated | relid=0 | w=41
- en:increased igm levels, polyclonal --
r_associated #0: 41 / 0.953 ->
en:neuroimmunology
n1=en:increased igm levels, polyclonal | n2=en:neuroimmunology | rel=r_associated | relid=0 | w=41
- en:increased igm levels, polyclonal --
r_associated #0: 40 / 0.93 ->
en:immunohematology
n1=en:increased igm levels, polyclonal | n2=en:immunohematology | rel=r_associated | relid=0 | w=40
- en:increased igm levels, polyclonal --
r_associated #0: 40 / 0.93 ->
en:qualitative abnormality of granulocyte
n1=en:increased igm levels, polyclonal | n2=en:qualitative abnormality of granulocyte | rel=r_associated | relid=0 | w=40
- en:increased igm levels, polyclonal --
r_associated #0: 40 / 0.93 ->
en:serratia marcescens infection
n1=en:increased igm levels, polyclonal | n2=en:serratia marcescens infection | rel=r_associated | relid=0 | w=40
- en:increased igm levels, polyclonal --
r_associated #0: 39 / 0.907 ->
en:absent t lymphocytes
n1=en:increased igm levels, polyclonal | n2=en:absent t lymphocytes | rel=r_associated | relid=0 | w=39
- en:increased igm levels, polyclonal --
r_associated #0: 39 / 0.907 ->
en:c8 deficiency
n1=en:increased igm levels, polyclonal | n2=en:c8 deficiency | rel=r_associated | relid=0 | w=39
- en:increased igm levels, polyclonal --
r_associated #0: 39 / 0.907 ->
en:decreased immunoglobulins, progressive
n1=en:increased igm levels, polyclonal | n2=en:decreased immunoglobulins, progressive | rel=r_associated | relid=0 | w=39
- en:increased igm levels, polyclonal --
r_associated #0: 39 / 0.907 ->
en:decreased t-cell proliferative response to mitogens
n1=en:increased igm levels, polyclonal | n2=en:decreased t-cell proliferative response to mitogens | rel=r_associated | relid=0 | w=39
- en:increased igm levels, polyclonal --
r_associated #0: 39 / 0.907 ->
en:impaired b-cell differentiation
n1=en:increased igm levels, polyclonal | n2=en:impaired b-cell differentiation | rel=r_associated | relid=0 | w=39
- en:increased igm levels, polyclonal --
r_associated #0: 39 / 0.907 ->
en:increased alpha-interferon activity
n1=en:increased igm levels, polyclonal | n2=en:increased alpha-interferon activity | rel=r_associated | relid=0 | w=39
- en:increased igm levels, polyclonal --
r_associated #0: 39 / 0.907 ->
en:increased susceptibility to systemic infections, particularly mycobacteria, candida, and salmonella
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to systemic infections, particularly mycobacteria, candida, and salmonella | rel=r_associated | relid=0 | w=39
- en:increased igm levels, polyclonal --
r_associated #0: 39 / 0.907 ->
en:mildly decreased or normal t-cell proliferative responses
n1=en:increased igm levels, polyclonal | n2=en:mildly decreased or normal t-cell proliferative responses | rel=r_associated | relid=0 | w=39
- en:increased igm levels, polyclonal --
r_associated #0: 39 / 0.907 ->
en:serum iga, igg, and ige severely deficient
n1=en:increased igm levels, polyclonal | n2=en:serum iga, igg, and ige severely deficient | rel=r_associated | relid=0 | w=39
- en:increased igm levels, polyclonal --
r_associated #0: 39 / 0.907 ->
en:t regulatory cells show poor function
n1=en:increased igm levels, polyclonal | n2=en:t regulatory cells show poor function | rel=r_associated | relid=0 | w=39
- en:increased igm levels, polyclonal --
r_associated #0: 39 / 0.907 ->
en:variable autoimmune disorders
n1=en:increased igm levels, polyclonal | n2=en:variable autoimmune disorders | rel=r_associated | relid=0 | w=39
- en:increased igm levels, polyclonal --
r_associated #0: 38 / 0.884 ->
en:autoantibodies
n1=en:increased igm levels, polyclonal | n2=en:autoantibodies | rel=r_associated | relid=0 | w=38
- en:increased igm levels, polyclonal --
r_associated #0: 38 / 0.884 ->
en:decreased cd19+ b cells
n1=en:increased igm levels, polyclonal | n2=en:decreased cd19+ b cells | rel=r_associated | relid=0 | w=38
- en:increased igm levels, polyclonal --
r_associated #0: 38 / 0.884 ->
en:decreased t cell proliferation
n1=en:increased igm levels, polyclonal | n2=en:decreased t cell proliferation | rel=r_associated | relid=0 | w=38
- en:increased igm levels, polyclonal --
r_associated #0: 38 / 0.884 ->
en:defect in v(d)j recombination process
n1=en:increased igm levels, polyclonal | n2=en:defect in v(d)j recombination process | rel=r_associated | relid=0 | w=38
- en:increased igm levels, polyclonal --
r_associated #0: 38 / 0.884 ->
en:dysfunctional alternative complement pathway
n1=en:increased igm levels, polyclonal | n2=en:dysfunctional alternative complement pathway | rel=r_associated | relid=0 | w=38
- en:increased igm levels, polyclonal --
r_associated #0: 38 / 0.884 ->
en:impaired t cell function
n1=en:increased igm levels, polyclonal | n2=en:impaired t cell function | rel=r_associated | relid=0 | w=38
- en:increased igm levels, polyclonal --
r_associated #0: 38 / 0.884 ->
en:low-to-absent igg, iga, ige
n1=en:increased igm levels, polyclonal | n2=en:low-to-absent igg, iga, ige | rel=r_associated | relid=0 | w=38
- en:increased igm levels, polyclonal --
r_associated #0: 37 / 0.86 ->
en:autoimmune disorders (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:autoimmune disorders (in some patients) | rel=r_associated | relid=0 | w=37
- en:increased igm levels, polyclonal --
r_associated #0: 37 / 0.86 ->
en:elevated igd
n1=en:increased igm levels, polyclonal | n2=en:elevated igd | rel=r_associated | relid=0 | w=37
- en:increased igm levels, polyclonal --
r_associated #0: 37 / 0.86 ->
en:escherichia coli infection
n1=en:increased igm levels, polyclonal | n2=en:escherichia coli infection | rel=r_associated | relid=0 | w=37
- en:increased igm levels, polyclonal --
r_associated #0: 37 / 0.86 ->
en:increased number of peripheral cd3+ t cells
n1=en:increased igm levels, polyclonal | n2=en:increased number of peripheral cd3+ t cells | rel=r_associated | relid=0 | w=37
- en:increased igm levels, polyclonal --
r_associated #0: 37 / 0.86 ->
en:lymphoid depletion
n1=en:increased igm levels, polyclonal | n2=en:lymphoid depletion | rel=r_associated | relid=0 | w=37
- en:increased igm levels, polyclonal --
r_associated #0: 37 / 0.86 ->
en:normal number of circulating lymphocytes
n1=en:increased igm levels, polyclonal | n2=en:normal number of circulating lymphocytes | rel=r_associated | relid=0 | w=37
- en:increased igm levels, polyclonal --
r_associated #0: 36 / 0.837 ->
en:b-cell lymphocytosis, b-cell, polyclonal
n1=en:increased igm levels, polyclonal | n2=en:b-cell lymphocytosis, b-cell, polyclonal | rel=r_associated | relid=0 | w=36
- en:increased igm levels, polyclonal --
r_associated #0: 36 / 0.837 ->
en:decreased circulating b cells
n1=en:increased igm levels, polyclonal | n2=en:decreased circulating b cells | rel=r_associated | relid=0 | w=36
- en:increased igm levels, polyclonal --
r_associated #0: 36 / 0.837 ->
en:decreased or absent il12r-beta-1 expression on t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased or absent il12r-beta-1 expression on t cells | rel=r_associated | relid=0 | w=36
- en:increased igm levels, polyclonal --
r_associated #0: 36 / 0.837 ->
en:hypogammaglobulinemia, profound
n1=en:increased igm levels, polyclonal | n2=en:hypogammaglobulinemia, profound | rel=r_associated | relid=0 | w=36
- en:increased igm levels, polyclonal --
r_associated #0: 36 / 0.837 ->
en:immunologic and autoimmune evaluation unremarkable
n1=en:increased igm levels, polyclonal | n2=en:immunologic and autoimmune evaluation unremarkable | rel=r_associated | relid=0 | w=36
- en:increased igm levels, polyclonal --
r_associated #0: 36 / 0.837 ->
en:low-normal iga levels
n1=en:increased igm levels, polyclonal | n2=en:low-normal iga levels | rel=r_associated | relid=0 | w=36
- en:increased igm levels, polyclonal --
r_associated #0: 36 / 0.837 ->
en:no evidence of immunodeficiency
n1=en:increased igm levels, polyclonal | n2=en:no evidence of immunodeficiency | rel=r_associated | relid=0 | w=36
- en:increased igm levels, polyclonal --
r_associated #0: 36 / 0.837 ->
en:normal levels of igm, iga, and igg
n1=en:increased igm levels, polyclonal | n2=en:normal levels of igm, iga, and igg | rel=r_associated | relid=0 | w=36
- en:increased igm levels, polyclonal --
r_associated #0: 36 / 0.837 ->
en:normal or elevated number of peripheral blood b cells
n1=en:increased igm levels, polyclonal | n2=en:normal or elevated number of peripheral blood b cells | rel=r_associated | relid=0 | w=36
- en:increased igm levels, polyclonal --
r_associated #0: 36 / 0.837 ->
en:poor proliferative response of t lymphocytes to specific antigens
n1=en:increased igm levels, polyclonal | n2=en:poor proliferative response of t lymphocytes to specific antigens | rel=r_associated | relid=0 | w=36
- en:increased igm levels, polyclonal --
r_associated #0: 36 / 0.837 ->
en:recurrent infections (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections (in some patients) | rel=r_associated | relid=0 | w=36
- en:increased igm levels, polyclonal --
r_associated #0: 36 / 0.837 ->
en:reduced natural killer cell activity
n1=en:increased igm levels, polyclonal | n2=en:reduced natural killer cell activity | rel=r_associated | relid=0 | w=36
- en:increased igm levels, polyclonal --
r_associated #0: 36 / 0.837 ->
en:small thymus
n1=en:increased igm levels, polyclonal | n2=en:small thymus | rel=r_associated | relid=0 | w=36
- en:increased igm levels, polyclonal --
r_associated #0: 36 / 0.837 ->
en:upregulation of alpha-interferon-stimulated genes
n1=en:increased igm levels, polyclonal | n2=en:upregulation of alpha-interferon-stimulated genes | rel=r_associated | relid=0 | w=36
- en:increased igm levels, polyclonal --
r_associated #0: 36 / 0.837 ->
en:varicella zoster infection
n1=en:increased igm levels, polyclonal | n2=en:varicella zoster infection | rel=r_associated | relid=0 | w=36
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:abnormal b cell function
n1=en:increased igm levels, polyclonal | n2=en:abnormal b cell function | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:absence of anti-thyroid antibodies
n1=en:increased igm levels, polyclonal | n2=en:absence of anti-thyroid antibodies | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:absence of pancreatic autoantibodies
n1=en:increased igm levels, polyclonal | n2=en:absence of pancreatic autoantibodies | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:absent mitogenic response to staphylococcus aureus cowan antigen (sac)
n1=en:increased igm levels, polyclonal | n2=en:absent mitogenic response to staphylococcus aureus cowan antigen (sac) | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:absent or small dysplastic thymus
n1=en:increased igm levels, polyclonal | n2=en:absent or small dysplastic thymus | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:agammaglobulinemia
n1=en:increased igm levels, polyclonal | n2=en:agammaglobulinemia | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:altered t-cell regulation
n1=en:increased igm levels, polyclonal | n2=en:altered t-cell regulation | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:associated with autoimmune disorders (systemic lupus erythematosus 152700 and hashimoto thyroiditis 140300)
n1=en:increased igm levels, polyclonal | n2=en:associated with autoimmune disorders (systemic lupus erythematosus 152700 and hashimoto thyroiditis 140300) | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:autoantibodies, transient
n1=en:increased igm levels, polyclonal | n2=en:autoantibodies, transient | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:b-cell lymphopenia (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:b-cell lymphopenia (in some patients) | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:c1q molecule present, but dysfunctional
n1=en:increased igm levels, polyclonal | n2=en:c1q molecule present, but dysfunctional | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:cells show impaired immunologic responses to immune stimulation
n1=en:increased igm levels, polyclonal | n2=en:cells show impaired immunologic responses to immune stimulation | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:decreased b cell survival and tolerance
n1=en:increased igm levels, polyclonal | n2=en:decreased b cell survival and tolerance | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:decreased cd27+ b cells
n1=en:increased igm levels, polyclonal | n2=en:decreased cd27+ b cells | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:decreased cd4+ cells subset
n1=en:increased igm levels, polyclonal | n2=en:decreased cd4+ cells subset | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:decreased cellular caspase-8 levels
n1=en:increased igm levels, polyclonal | n2=en:decreased cellular caspase-8 levels | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:decreased iga, plasma and secretory
n1=en:increased igm levels, polyclonal | n2=en:decreased iga, plasma and secretory | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:decreased numbers of circulating nk cells (less than 5%)
n1=en:increased igm levels, polyclonal | n2=en:decreased numbers of circulating nk cells (less than 5%) | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:decreased numbers of long-term memory cd8+ t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased numbers of long-term memory cd8+ t cells | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:decreased serum complement factor i
n1=en:increased igm levels, polyclonal | n2=en:decreased serum complement factor i | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:defective antibody response
n1=en:increased igm levels, polyclonal | n2=en:defective antibody response | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:defective intracellular signaling in lymphocytes
n1=en:increased igm levels, polyclonal | n2=en:defective intracellular signaling in lymphocytes | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:dermatomyositis
n1=en:increased igm levels, polyclonal | n2=en:dermatomyositis | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:diminished proliferative response of t cells to allogenic cells, mitogens, and antigens
n1=en:increased igm levels, polyclonal | n2=en:diminished proliferative response of t cells to allogenic cells, mitogens, and antigens | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:enterovirus infections
n1=en:increased igm levels, polyclonal | n2=en:enterovirus infections | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:fulminant infectious mononucleosis
n1=en:increased igm levels, polyclonal | n2=en:fulminant infectious mononucleosis | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:hypergammaglobulinemia
n1=en:increased igm levels, polyclonal | n2=en:hypergammaglobulinemia | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:hyperglobulinemia
n1=en:increased igm levels, polyclonal | n2=en:hyperglobulinemia | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:hyperinflammatory state (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:hyperinflammatory state (in some patients) | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:hypogammaglobulinemia (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:hypogammaglobulinemia (in some patients) | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:immunoglobulin a decreased
n1=en:increased igm levels, polyclonal | n2=en:immunoglobulin a decreased | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:immunologic evaluation unremarkable
n1=en:increased igm levels, polyclonal | n2=en:immunologic evaluation unremarkable | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:impaired cellular responses to certain cytokine pathways
n1=en:increased igm levels, polyclonal | n2=en:impaired cellular responses to certain cytokine pathways | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:impaired lymphocyte apoptosis
n1=en:increased igm levels, polyclonal | n2=en:impaired lymphocyte apoptosis | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:increased ige impaired nk cell activity
n1=en:increased igm levels, polyclonal | n2=en:increased ige impaired nk cell activity | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:increased igm (1 patient)
n1=en:increased igm levels, polyclonal | n2=en:increased igm (1 patient) | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:increased proportion of cd19+ b cells
n1=en:increased igm levels, polyclonal | n2=en:increased proportion of cd19+ b cells | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:invasive bacterial, viral, and mycobacterial infections
n1=en:increased igm levels, polyclonal | n2=en:invasive bacterial, viral, and mycobacterial infections | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:low igg with antibody deficiency
n1=en:increased igm levels, polyclonal | n2=en:low igg with antibody deficiency | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:low naive t cells
n1=en:increased igm levels, polyclonal | n2=en:low naive t cells | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:lupus erythematosus, systemic
n1=en:increased igm levels, polyclonal | n2=en:lupus erythematosus, systemic | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:lymphohistiocytosis
n1=en:increased igm levels, polyclonal | n2=en:lymphohistiocytosis | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:lymphoproliferation
n1=en:increased igm levels, polyclonal | n2=en:lymphoproliferation | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:markedly depressed t lymphocyte proportion
n1=en:increased igm levels, polyclonal | n2=en:markedly depressed t lymphocyte proportion | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:moderate-low complement c3
n1=en:increased igm levels, polyclonal | n2=en:moderate-low complement c3 | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:moderately depressed antibody response to polysaccharide antigens
n1=en:increased igm levels, polyclonal | n2=en:moderately depressed antibody response to polysaccharide antigens | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:moderately elevated ige
n1=en:increased igm levels, polyclonal | n2=en:moderately elevated ige | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:molecular immunology
n1=en:increased igm levels, polyclonal | n2=en:molecular immunology | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:neoplasm/cancer immunology
n1=en:increased igm levels, polyclonal | n2=en:neoplasm/cancer immunology | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:neutrophils show defective intracellular nadph oxidase production
n1=en:increased igm levels, polyclonal | n2=en:neutrophils show defective intracellular nadph oxidase production | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:no immunodeficiency
n1=en:increased igm levels, polyclonal | n2=en:no immunodeficiency | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:no response to pneumococcal vaccination
n1=en:increased igm levels, polyclonal | n2=en:no response to pneumococcal vaccination | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:non-malignant mixed lymphohistiocytic infiltration of the reticuloendothelial system
n1=en:increased igm levels, polyclonal | n2=en:non-malignant mixed lymphohistiocytic infiltration of the reticuloendothelial system | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:normal b cell function
n1=en:increased igm levels, polyclonal | n2=en:normal b cell function | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:normal b-cell (cd19+) count
n1=en:increased igm levels, polyclonal | n2=en:normal b-cell (cd19+) count | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:normal cell mediated immunity
n1=en:increased igm levels, polyclonal | n2=en:normal cell mediated immunity | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:normal immune profile
n1=en:increased igm levels, polyclonal | n2=en:normal immune profile | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:normal number of natural killer cells
n1=en:increased igm levels, polyclonal | n2=en:normal number of natural killer cells | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:normal numbers of b cells
n1=en:increased igm levels, polyclonal | n2=en:normal numbers of b cells | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:normal serologic immunoglobulin production to vaccination
n1=en:increased igm levels, polyclonal | n2=en:normal serologic immunoglobulin production to vaccination | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:normal thymus
n1=en:increased igm levels, polyclonal | n2=en:normal thymus | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:poor antigen specific t-cell proliferation
n1=en:increased igm levels, polyclonal | n2=en:poor antigen specific t-cell proliferation | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:pregnancy immunology
n1=en:increased igm levels, polyclonal | n2=en:pregnancy immunology | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:properdin deficiency, x-linked
n1=en:increased igm levels, polyclonal | n2=en:properdin deficiency, x-linked | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:pseudomonas infections
n1=en:increased igm levels, polyclonal | n2=en:pseudomonas infections | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:recurrent candidal infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent candidal infections | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:recurrent infections (in severe cases)
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections (in severe cases) | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:recurrent infections (otitis media and bacterial pneumonia)
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections (otitis media and bacterial pneumonia) | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:recurrent infections in infancy and early childhood
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections in infancy and early childhood | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:recurrent staphylococcal and gram-negative infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent staphylococcal and gram-negative infections | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:recurrent staphylococcus aureus infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent staphylococcus aureus infections | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:recurrent upper respiratory tract infection
n1=en:increased igm levels, polyclonal | n2=en:recurrent upper respiratory tract infection | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:reduced cd4 t-lymphocyte counts
n1=en:increased igm levels, polyclonal | n2=en:reduced cd4 t-lymphocyte counts | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:reduced cd4+/cd8+ ratio with cd8+ predominance
n1=en:increased igm levels, polyclonal | n2=en:reduced cd4+/cd8+ ratio with cd8+ predominance | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:reduced natural killer cell number
n1=en:increased igm levels, polyclonal | n2=en:reduced natural killer cell number | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:reduced/absent cd3+ t cells
n1=en:increased igm levels, polyclonal | n2=en:reduced/absent cd3+ t cells | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:relative t-cell anergy
n1=en:increased igm levels, polyclonal | n2=en:relative t-cell anergy | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:susceptibility to infection by mycobacterium leprae causing leprosy
n1=en:increased igm levels, polyclonal | n2=en:susceptibility to infection by mycobacterium leprae causing leprosy | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:susceptibility to infection with human herpesvirus
n1=en:increased igm levels, polyclonal | n2=en:susceptibility to infection with human herpesvirus | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:systemic inflammatory response (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:systemic inflammatory response (in some patients) | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:systemic lupus erythematosus (in rare mutation carriers unaffected by a hematologic malignancy)
n1=en:increased igm levels, polyclonal | n2=en:systemic lupus erythematosus (in rare mutation carriers unaffected by a hematologic malignancy) | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:thrombocytopenia (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:thrombocytopenia (in some patients) | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:variable (often increased) number of activated cd45ro+, dr+ circulating t cells
n1=en:increased igm levels, polyclonal | n2=en:variable (often increased) number of activated cd45ro+, dr+ circulating t cells | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 35 / 0.814 ->
en:variable antibody response to vaccination
n1=en:increased igm levels, polyclonal | n2=en:variable antibody response to vaccination | rel=r_associated | relid=0 | w=35
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:abnormal delayed hypersensitivity skin test
n1=en:increased igm levels, polyclonal | n2=en:abnormal delayed hypersensitivity skin test | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:abnormality of humoral immunity
n1=en:increased igm levels, polyclonal | n2=en:abnormality of humoral immunity | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:abnormally large monocytes with vacuoles
n1=en:increased igm levels, polyclonal | n2=en:abnormally large monocytes with vacuoles | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:absence of bactericidal oxidative 'respiratory burst' in phagocytes
n1=en:increased igm levels, polyclonal | n2=en:absence of bactericidal oxidative 'respiratory burst' in phagocytes | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:absent or severely reduced numbers of b cells
n1=en:increased igm levels, polyclonal | n2=en:absent or severely reduced numbers of b cells | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:acetylcholine receptor (achr) autoantibodies are found in a subset of patients
n1=en:increased igm levels, polyclonal | n2=en:acetylcholine receptor (achr) autoantibodies are found in a subset of patients | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:activation of the alternative complement pathway and depletion of complement components
n1=en:increased igm levels, polyclonal | n2=en:activation of the alternative complement pathway and depletion of complement components | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:associated with autoimmune disorders (e.g., diabetes mellitus, thyroiditis, pernicious anemia, vitiligo)
n1=en:increased igm levels, polyclonal | n2=en:associated with autoimmune disorders (e.g., diabetes mellitus, thyroiditis, pernicious anemia, vitiligo) | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:autoimmune disorders (i.e., itp, juvenile rheumatoid arthritis (jra), hypothyroidism, crohn disease)
n1=en:increased igm levels, polyclonal | n2=en:autoimmune disorders (i.e., itp, juvenile rheumatoid arthritis (jra), hypothyroidism, crohn disease) | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:autoimmune neutropenia (less common)
n1=en:increased igm levels, polyclonal | n2=en:autoimmune neutropenia (less common) | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:autoimmunity (rare)
n1=en:increased igm levels, polyclonal | n2=en:autoimmunity (rare) | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:autoimmunity to pancreatic beta cells (rare)
n1=en:increased igm levels, polyclonal | n2=en:autoimmunity to pancreatic beta cells (rare) | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:autoinflammation, systemic
n1=en:increased igm levels, polyclonal | n2=en:autoinflammation, systemic | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:b cells lack surface cd19 expression
n1=en:increased igm levels, polyclonal | n2=en:b cells lack surface cd19 expression | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:binucleated lymphocytes
n1=en:increased igm levels, polyclonal | n2=en:binucleated lymphocytes | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:cancer immunology
n1=en:increased igm levels, polyclonal | n2=en:cancer immunology | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:complement component consumption
n1=en:increased igm levels, polyclonal | n2=en:complement component consumption | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:congenital absence of thymus
n1=en:increased igm levels, polyclonal | n2=en:congenital absence of thymus | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:decreased cd3+ cells subset
n1=en:increased igm levels, polyclonal | n2=en:decreased cd3+ cells subset | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:decreased cd4+ t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased cd4+ t cells | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:decreased levels of naive t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased levels of naive t cells | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:decreased nk levels (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:decreased nk levels (in some patients) | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:decreased number of tcr alpha/beta+ t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased number of tcr alpha/beta+ t cells | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:decreased numbers of b-cell precursors seen in bone aspirate
n1=en:increased igm levels, polyclonal | n2=en:decreased numbers of b-cell precursors seen in bone aspirate | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:defective antibody production
n1=en:increased igm levels, polyclonal | n2=en:defective antibody production | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:delayed wound healing with normal immune system
n1=en:increased igm levels, polyclonal | n2=en:delayed wound healing with normal immune system | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:elevated il6 (147620)
n1=en:increased igm levels, polyclonal | n2=en:elevated il6 (147620) | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:evidence of ebv infection
n1=en:increased igm levels, polyclonal | n2=en:evidence of ebv infection | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:frequent bacterial, viral, protozoan, and fungal infections
n1=en:increased igm levels, polyclonal | n2=en:frequent bacterial, viral, protozoan, and fungal infections | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:frequent infections in childhood
n1=en:increased igm levels, polyclonal | n2=en:frequent infections in childhood | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:generalized lymphohistiocytic infiltrates in late phase
n1=en:increased igm levels, polyclonal | n2=en:generalized lymphohistiocytic infiltrates in late phase | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:granuloma formation
n1=en:increased igm levels, polyclonal | n2=en:granuloma formation | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:hay fever
n1=en:increased igm levels, polyclonal | n2=en:hay fever | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:hemophagocytosis in bone marrow and lymph nodes
n1=en:increased igm levels, polyclonal | n2=en:hemophagocytosis in bone marrow and lymph nodes | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:hla antigens cw6, b13, b17 associated with psoriasis
n1=en:increased igm levels, polyclonal | n2=en:hla antigens cw6, b13, b17 associated with psoriasis | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:hypersensitivity
n1=en:increased igm levels, polyclonal | n2=en:hypersensitivity | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:hypogammaglobulinemia
n1=en:increased igm levels, polyclonal | n2=en:hypogammaglobulinemia | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:igm immunodeficiency (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:igm immunodeficiency (in some patients) | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:immunity
n1=en:increased igm levels, polyclonal | n2=en:immunity | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:immunoglobulin deficiency (iga, igg, igm)
n1=en:increased igm levels, polyclonal | n2=en:immunoglobulin deficiency (iga, igg, igm) | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:immunoregulation
n1=en:increased igm levels, polyclonal | n2=en:immunoregulation | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:immunotoxicity
n1=en:increased igm levels, polyclonal | n2=en:immunotoxicity | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:impaired antibody production (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:impaired antibody production (in some patients) | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:impaired cellular and humoral immunity
n1=en:increased igm levels, polyclonal | n2=en:impaired cellular and humoral immunity | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:impaired ig class switch recombination
n1=en:increased igm levels, polyclonal | n2=en:impaired ig class switch recombination | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:impaired production of interferon-gamma in response to mycobacterial infection
n1=en:increased igm levels, polyclonal | n2=en:impaired production of interferon-gamma in response to mycobacterial infection | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:impaired survival of mature t cells
n1=en:increased igm levels, polyclonal | n2=en:impaired survival of mature t cells | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:impaired t cell activation
n1=en:increased igm levels, polyclonal | n2=en:impaired t cell activation | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:impaired t-cell proliferation to certain stimuli
n1=en:increased igm levels, polyclonal | n2=en:impaired t-cell proliferation to certain stimuli | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:inability to mount antibody response to antigen
n1=en:increased igm levels, polyclonal | n2=en:inability to mount antibody response to antigen | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:increased igm level
n1=en:increased igm levels, polyclonal | n2=en:increased igm level | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:increased number of circulating lymphocytes
n1=en:increased igm levels, polyclonal | n2=en:increased number of circulating lymphocytes | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:increased susceptibility to candidal infections
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to candidal infections | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:increased susceptibility to infections (bacterial, fungal, and viral)
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to infections (bacterial, fungal, and viral) | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:increased susceptibility to mycobacteria and intracellular bacteria
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to mycobacteria and intracellular bacteria | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:increased transitional b cells
n1=en:increased igm levels, polyclonal | n2=en:increased transitional b cells | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:infectious disease immunology
n1=en:increased igm levels, polyclonal | n2=en:infectious disease immunology | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:infectious mononucleosis
n1=en:increased igm levels, polyclonal | n2=en:infectious mononucleosis | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:lack of circulating dendritic cells
n1=en:increased igm levels, polyclonal | n2=en:lack of circulating dendritic cells | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:low igg
n1=en:increased igm levels, polyclonal | n2=en:low igg | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:low igg and iga
n1=en:increased igm levels, polyclonal | n2=en:low igg and iga | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:low levels of memory b cells
n1=en:increased igm levels, polyclonal | n2=en:low levels of memory b cells | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:lymph node architecture severely altered: lack of follicles, depletion of lymphocytes, and increased proportion of interdigitating reticular cells and eosinophils
n1=en:increased igm levels, polyclonal | n2=en:lymph node architecture severely altered: lack of follicles, depletion of lymphocytes, and increased proportion of interdigitating reticular cells and eosinophils | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:lymphadenitis subsequent to bcg vaccination (in 1 patient)
n1=en:increased igm levels, polyclonal | n2=en:lymphadenitis subsequent to bcg vaccination (in 1 patient) | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:lymphoid hyperplasia
n1=en:increased igm levels, polyclonal | n2=en:lymphoid hyperplasia | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:lymphoid hypoplasia
n1=en:increased igm levels, polyclonal | n2=en:lymphoid hypoplasia | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:markedly reduced cd3+ proportion
n1=en:increased igm levels, polyclonal | n2=en:markedly reduced cd3+ proportion | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:markedly reduced neutrophil motility
n1=en:increased igm levels, polyclonal | n2=en:markedly reduced neutrophil motility | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:myeloid proliferation
n1=en:increased igm levels, polyclonal | n2=en:myeloid proliferation | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:neuroimmunomodulation
n1=en:increased igm levels, polyclonal | n2=en:neuroimmunomodulation | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:no clinical signs of immunodeficiency
n1=en:increased igm levels, polyclonal | n2=en:no clinical signs of immunodeficiency | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:no concurrent allergies
n1=en:increased igm levels, polyclonal | n2=en:no concurrent allergies | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:no severe viral infections
n1=en:increased igm levels, polyclonal | n2=en:no severe viral infections | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:non-caseating granulomas (bone marrow and lymph nodes)
n1=en:increased igm levels, polyclonal | n2=en:non-caseating granulomas (bone marrow and lymph nodes) | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:normal igg, iga, igm, ige levels
n1=en:increased igm levels, polyclonal | n2=en:normal igg, iga, igm, ige levels | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:normal number of b cells
n1=en:increased igm levels, polyclonal | n2=en:normal number of b cells | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:normal number of t cells
n1=en:increased igm levels, polyclonal | n2=en:normal number of t cells | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:normal numbers and function of t cells
n1=en:increased igm levels, polyclonal | n2=en:normal numbers and function of t cells | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:normal numbers of circulating t cells
n1=en:increased igm levels, polyclonal | n2=en:normal numbers of circulating t cells | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:normal or reduced numbers of b cells
n1=en:increased igm levels, polyclonal | n2=en:normal or reduced numbers of b cells | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:normal t-cell numbers
n1=en:increased igm levels, polyclonal | n2=en:normal t-cell numbers | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:perirectal abscess
n1=en:increased igm levels, polyclonal | n2=en:perirectal abscess | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:recurrent infections at variable sites (sinusitis, otitis media, facial cellulitis, adenitis, blepharitis, conjunctivitis, gastroenteritis)
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections at variable sites (sinusitis, otitis media, facial cellulitis, adenitis, blepharitis, conjunctivitis, gastroenteritis) | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:recurrent infections, bacterial, viral, fungal, myobacterial
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections, bacterial, viral, fungal, myobacterial | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:recurrent infections, particularly herpes viral
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections, particularly herpes viral | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:reduced production of interleukin 2 by mitogen stimulated blood lymphocytes
n1=en:increased igm levels, polyclonal | n2=en:reduced production of interleukin 2 by mitogen stimulated blood lymphocytes | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:relatively increased number of natural killer cells
n1=en:increased igm levels, polyclonal | n2=en:relatively increased number of natural killer cells | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:serum complement decreased
n1=en:increased igm levels, polyclonal | n2=en:serum complement decreased | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:susceptibility to bacterial infections due to poor skin integrity
n1=en:increased igm levels, polyclonal | n2=en:susceptibility to bacterial infections due to poor skin integrity | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:susceptibility to ebv and cmv infections
n1=en:increased igm levels, polyclonal | n2=en:susceptibility to ebv and cmv infections | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:susceptibility to infections
n1=en:increased igm levels, polyclonal | n2=en:susceptibility to infections | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:susceptible to vaccine-induced polio
n1=en:increased igm levels, polyclonal | n2=en:susceptible to vaccine-induced polio | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:thymoma
n1=en:increased igm levels, polyclonal | n2=en:thymoma | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:thyroid hormone deficiency (1 patient)
n1=en:increased igm levels, polyclonal | n2=en:thyroid hormone deficiency (1 patient) | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:vacuolated lymphocytes
n1=en:increased igm levels, polyclonal | n2=en:vacuolated lymphocytes | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:variably impaired t-cell proliferative responses
n1=en:increased igm levels, polyclonal | n2=en:variably impaired t-cell proliferative responses | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:vasculitis
n1=en:increased igm levels, polyclonal | n2=en:vasculitis | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 34 / 0.791 ->
en:very low b cells
n1=en:increased igm levels, polyclonal | n2=en:very low b cells | rel=r_associated | relid=0 | w=34
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:abnormal lymphocytic accumulation in non-lymphoid tissue
n1=en:increased igm levels, polyclonal | n2=en:abnormal lymphocytic accumulation in non-lymphoid tissue | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:abnormal ratios of cd4+ helper t cells
n1=en:increased igm levels, polyclonal | n2=en:abnormal ratios of cd4+ helper t cells | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:absence of pus formation at site of infection
n1=en:increased igm levels, polyclonal | n2=en:absence of pus formation at site of infection | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:absent delayed hypersensitivity skin test
n1=en:increased igm levels, polyclonal | n2=en:absent delayed hypersensitivity skin test | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:abundant cd4+ t cells
n1=en:increased igm levels, polyclonal | n2=en:abundant cd4+ t cells | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:activation of the complement system
n1=en:increased igm levels, polyclonal | n2=en:activation of the complement system | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:approximately 60% of patients have anti-gad65 antibodies
n1=en:increased igm levels, polyclonal | n2=en:approximately 60% of patients have anti-gad65 antibodies | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:association with autoimmune diseases
n1=en:increased igm levels, polyclonal | n2=en:association with autoimmune diseases | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:autoantibodies (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:autoantibodies (in some patients) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:autoimmune disease (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:autoimmune disease (in some patients) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:autoimmune diseases
n1=en:increased igm levels, polyclonal | n2=en:autoimmune diseases | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:cow milk allergy
n1=en:increased igm levels, polyclonal | n2=en:cow milk allergy | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:decreased b cells (family b)
n1=en:increased igm levels, polyclonal | n2=en:decreased b cells (family b) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:decreased cd4+ and cd3+/cd4+ lymphocytes
n1=en:increased igm levels, polyclonal | n2=en:decreased cd4+ and cd3+/cd4+ lymphocytes | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:decreased circulation t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased circulation t cells | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:decreased cytotoxic activity of cd8+ t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased cytotoxic activity of cd8+ t cells | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:decreased invariant nk t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased invariant nk t cells | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:decreased numbers of b cells
n1=en:increased igm levels, polyclonal | n2=en:decreased numbers of b cells | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:decreased numbers of natural killer cells (nk)
n1=en:increased igm levels, polyclonal | n2=en:decreased numbers of natural killer cells (nk) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:decreased numbers of t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased numbers of t cells | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:decreased serum complement factor h (cfh, 134370)
n1=en:increased igm levels, polyclonal | n2=en:decreased serum complement factor h (cfh, 134370) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:decreased serum igm
n1=en:increased igm levels, polyclonal | n2=en:decreased serum igm | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:defective b cell class-switching
n1=en:increased igm levels, polyclonal | n2=en:defective b cell class-switching | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:defective macrophage function
n1=en:increased igm levels, polyclonal | n2=en:defective macrophage function | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:defective natural killer cell (nk) activation
n1=en:increased igm levels, polyclonal | n2=en:defective natural killer cell (nk) activation | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:defective neutrophil adhesion to endothelial cells
n1=en:increased igm levels, polyclonal | n2=en:defective neutrophil adhesion to endothelial cells | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:defective response of b and t cells to activation
n1=en:increased igm levels, polyclonal | n2=en:defective response of b and t cells to activation | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:disseminated infection with dimorphic fungi (coccidioides and histoplasma)
n1=en:increased igm levels, polyclonal | n2=en:disseminated infection with dimorphic fungi (coccidioides and histoplasma) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:foot ulcer
n1=en:increased igm levels, polyclonal | n2=en:foot ulcer | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:hemophagocytosis (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:hemophagocytosis (in some patients) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:herpes simplex virus infection, mucocutaneous
n1=en:increased igm levels, polyclonal | n2=en:herpes simplex virus infection, mucocutaneous | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:humoral defect (in some)
n1=en:increased igm levels, polyclonal | n2=en:humoral defect (in some) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:hyperinflammatory disorder
n1=en:increased igm levels, polyclonal | n2=en:hyperinflammatory disorder | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:hyperproliferation of effector t cells
n1=en:increased igm levels, polyclonal | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:immune defect due to a t cell deficit
n1=en:increased igm levels, polyclonal | n2=en:immune defect due to a t cell deficit | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:immunodeficiency syndrome
n1=en:increased igm levels, polyclonal | n2=en:immunodeficiency syndrome | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:impaired antiviral response to alpha-interferon signaling
n1=en:increased igm levels, polyclonal | n2=en:impaired antiviral response to alpha-interferon signaling | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:impaired lymphocyte proliferation response to malignancy
n1=en:increased igm levels, polyclonal | n2=en:impaired lymphocyte proliferation response to malignancy | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:increase in b cell number
n1=en:increased igm levels, polyclonal | n2=en:increase in b cell number | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:increase in cd16+ activated granulocytes
n1=en:increased igm levels, polyclonal | n2=en:increase in cd16+ activated granulocytes | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:increased activated cd8+ t cells
n1=en:increased igm levels, polyclonal | n2=en:increased activated cd8+ t cells | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:increased delta-gamma cd8+ t cells (family b)
n1=en:increased igm levels, polyclonal | n2=en:increased delta-gamma cd8+ t cells (family b) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:increased ig
n1=en:increased igm levels, polyclonal | n2=en:increased ig | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:increased number of cd4-/cd8- t cells expressing alpha/beta t-cell receptors
n1=en:increased igm levels, polyclonal | n2=en:increased number of cd4-/cd8- t cells expressing alpha/beta t-cell receptors | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:increased susceptibility to bacterial infections
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to bacterial infections | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:increased susceptibility to streptococcus pneumoniae infections
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to streptococcus pneumoniae infections | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:low specific antibody titers (e.g., tetanus, polio virus, mumps, rubella)
n1=en:increased igm levels, polyclonal | n2=en:low specific antibody titers (e.g., tetanus, polio virus, mumps, rubella) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:lupus-like syndrome (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:lupus-like syndrome (in some patients) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:lymph node hyperplasia
n1=en:increased igm levels, polyclonal | n2=en:lymph node hyperplasia | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:lymphadenopathy
n1=en:increased igm levels, polyclonal | n2=en:lymphadenopathy | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:lymphadenopathy, generalized (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:lymphadenopathy, generalized (in some patients) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:mildly decreased proliferative responses of t cells
n1=en:increased igm levels, polyclonal | n2=en:mildly decreased proliferative responses of t cells | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:mycobacterium infections
n1=en:increased igm levels, polyclonal | n2=en:mycobacterium infections | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:mycoses
n1=en:increased igm levels, polyclonal | n2=en:mycoses | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:no evidence of intrauterine or perinatal infection
n1=en:increased igm levels, polyclonal | n2=en:no evidence of intrauterine or perinatal infection | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:normal or increased igm
n1=en:increased igm levels, polyclonal | n2=en:normal or increased igm | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:normal t cells
n1=en:increased igm levels, polyclonal | n2=en:normal t cells | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:poor antibody response
n1=en:increased igm levels, polyclonal | n2=en:poor antibody response | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:post-vaccination varicella (in 1 patient)
n1=en:increased igm levels, polyclonal | n2=en:post-vaccination varicella (in 1 patient) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:recurrent bacterial and viral infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent bacterial and viral infections | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:recurrent febrile illnesses
n1=en:increased igm levels, polyclonal | n2=en:recurrent febrile illnesses | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:recurrent infections, particularly to viruses and fungi
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections, particularly to viruses and fungi | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:recurrent severe infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent severe infections | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:recurrent skin and respiratory infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent skin and respiratory infections | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:recurrent viral infection
n1=en:increased igm levels, polyclonal | n2=en:recurrent viral infection | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:reduced cd3 t-lymphocyte counts
n1=en:increased igm levels, polyclonal | n2=en:reduced cd3 t-lymphocyte counts | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:reduced number of naive t cells (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:reduced number of naive t cells (in some patients) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:repeated invasive infections
n1=en:increased igm levels, polyclonal | n2=en:repeated invasive infections | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:residual rag1 and rag2 activity
n1=en:increased igm levels, polyclonal | n2=en:residual rag1 and rag2 activity | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:secondary respiratory infections
n1=en:increased igm levels, polyclonal | n2=en:secondary respiratory infections | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:severe viral infections
n1=en:increased igm levels, polyclonal | n2=en:severe viral infections | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:severely reduced response to candida and tetanus toxoid antigens
n1=en:increased igm levels, polyclonal | n2=en:severely reduced response to candida and tetanus toxoid antigens | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:severely reduced response to mitogens
n1=en:increased igm levels, polyclonal | n2=en:severely reduced response to mitogens | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:sjogren's syndrome
n1=en:increased igm levels, polyclonal | n2=en:sjogren's syndrome | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:small lymph nodes, which lack paracortical regions
n1=en:increased igm levels, polyclonal | n2=en:small lymph nodes, which lack paracortical regions | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:susceptibility to chickenpox
n1=en:increased igm levels, polyclonal | n2=en:susceptibility to chickenpox | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:systemic lupus erythematosus (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:systemic lupus erythematosus (in some patients) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:t-cell hyporesponsiveness (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:t-cell hyporesponsiveness (in some patients) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:t-lymphocytopenia
n1=en:increased igm levels, polyclonal | n2=en:t-lymphocytopenia | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:tissue biopsy shows granulomas
n1=en:increased igm levels, polyclonal | n2=en:tissue biopsy shows granulomas | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:tnf continuously elevated (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:tnf continuously elevated (in some patients) | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:undetectable/absent peripheral lymph nodes
n1=en:increased igm levels, polyclonal | n2=en:undetectable/absent peripheral lymph nodes | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 32 / 0.744 ->
en:vitiligo
n1=en:increased igm levels, polyclonal | n2=en:vitiligo | rel=r_associated | relid=0 | w=32
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:abnormality of b cell physiology
n1=en:increased igm levels, polyclonal | n2=en:abnormality of b cell physiology | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:absence of lymph node germinal center
n1=en:increased igm levels, polyclonal | n2=en:absence of lymph node germinal center | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:absent cellular immunity
n1=en:increased igm levels, polyclonal | n2=en:absent cellular immunity | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:absent peripheral blood b cells
n1=en:increased igm levels, polyclonal | n2=en:absent peripheral blood b cells | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:absent t cells
n1=en:increased igm levels, polyclonal | n2=en:absent t cells | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:activated t-helper cells
n1=en:increased igm levels, polyclonal | n2=en:activated t-helper cells | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:antibody-dependent cellular cytotoxicity of nk cells is unaffected
n1=en:increased igm levels, polyclonal | n2=en:antibody-dependent cellular cytotoxicity of nk cells is unaffected | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:arrest of b cell development at very early stage
n1=en:increased igm levels, polyclonal | n2=en:arrest of b cell development at very early stage | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:cd4/cd8 ratio decreased
n1=en:increased igm levels, polyclonal | n2=en:cd4/cd8 ratio decreased | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:chronic viral infections (1 patient)
n1=en:increased igm levels, polyclonal | n2=en:chronic viral infections (1 patient) | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:congenital hypoplasia of thymus
n1=en:increased igm levels, polyclonal | n2=en:congenital hypoplasia of thymus | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:decreased cd3 expression on t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased cd3 expression on t cells | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:decreased memory b cells
n1=en:increased igm levels, polyclonal | n2=en:decreased memory b cells | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:decreased memory b cells (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:decreased memory b cells (in some patients) | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:decreased natural killer cells
n1=en:increased igm levels, polyclonal | n2=en:decreased natural killer cells | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:decreased nk cells, particularly nk cell precursors
n1=en:increased igm levels, polyclonal | n2=en:decreased nk cells, particularly nk cell precursors | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:decreased numbers of naive cd4+ and cd8+ t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased numbers of naive cd4+ and cd8+ t cells | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:decreased or absent pre-b cells
n1=en:increased igm levels, polyclonal | n2=en:decreased or absent pre-b cells | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:decreased t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased t cells | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:defective antibody production against polysaccharide-based vaccines
n1=en:increased igm levels, polyclonal | n2=en:defective antibody production against polysaccharide-based vaccines | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:defective il21r-related signaling
n1=en:increased igm levels, polyclonal | n2=en:defective il21r-related signaling | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:defective production of nfkb1-dependent cytokines by white blood cells
n1=en:increased igm levels, polyclonal | n2=en:defective production of nfkb1-dependent cytokines by white blood cells | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:deficient nk-cell mediated spontaneous and antibody-mediated cytotoxicity
n1=en:increased igm levels, polyclonal | n2=en:deficient nk-cell mediated spontaneous and antibody-mediated cytotoxicity | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:exaggerated cellular immune processes
n1=en:increased igm levels, polyclonal | n2=en:exaggerated cellular immune processes | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:extrahepatic reticuloendothelial system spared
n1=en:increased igm levels, polyclonal | n2=en:extrahepatic reticuloendothelial system spared | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:food allergy
n1=en:increased igm levels, polyclonal | n2=en:food allergy | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:giant germinal centers in lymph nodes
n1=en:increased igm levels, polyclonal | n2=en:giant germinal centers in lymph nodes | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:granulomatous disease (in rare mutation carriers unaffected by a hematologic malignancy)
n1=en:increased igm levels, polyclonal | n2=en:granulomatous disease (in rare mutation carriers unaffected by a hematologic malignancy) | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:hemophagocytic syndrome (hs) characterized by acute onset of uncontrolled t-lymphocyte and macrophage activation
n1=en:increased igm levels, polyclonal | n2=en:hemophagocytic syndrome (hs) characterized by acute onset of uncontrolled t-lymphocyte and macrophage activation | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:hypogammaglobulinemia (1 patient)
n1=en:increased igm levels, polyclonal | n2=en:hypogammaglobulinemia (1 patient) | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:impaired immune responses
n1=en:increased igm levels, polyclonal | n2=en:impaired immune responses | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:impaired interferon production
n1=en:increased igm levels, polyclonal | n2=en:impaired interferon production | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:impaired t cell proliferation and activation
n1=en:increased igm levels, polyclonal | n2=en:impaired t cell proliferation and activation | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:increase in cd8+ t cells (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:increase in cd8+ t cells (in some patients) | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:increased circulating transitional b cells (cd19+cd38+igm+)
n1=en:increased igm levels, polyclonal | n2=en:increased circulating transitional b cells (cd19+cd38+igm+) | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:increased il6, episodic
n1=en:increased igm levels, polyclonal | n2=en:increased il6, episodic | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:increased serum ige, iga, igg
n1=en:increased igm levels, polyclonal | n2=en:increased serum ige, iga, igg | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:increased susceptibility to certain bacterial infections, especially neisseria meningitidis
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to certain bacterial infections, especially neisseria meningitidis | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:increased susceptibility to ebv infection
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to ebv infection | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:increased susceptibility to infections
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to infections | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:increased t cell activation
n1=en:increased igm levels, polyclonal | n2=en:increased t cell activation | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:lack of acquired antibodies
n1=en:increased igm levels, polyclonal | n2=en:lack of acquired antibodies | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:lack of cd27 expression on lymphocytes
n1=en:increased igm levels, polyclonal | n2=en:lack of cd27 expression on lymphocytes | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:leukocytosis
n1=en:increased igm levels, polyclonal | n2=en:leukocytosis | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:lymph nodes show florid reactive follicular hyperplasia and marked paracortical expansion with immunoblasts and plasma cells
n1=en:increased igm levels, polyclonal | n2=en:lymph nodes show florid reactive follicular hyperplasia and marked paracortical expansion with immunoblasts and plasma cells | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:lymphadenopathy (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:lymphadenopathy (in some patients) | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:neutropenia (in most patients)
n1=en:increased igm levels, polyclonal | n2=en:neutropenia (in most patients) | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:no immune defects reported
n1=en:increased igm levels, polyclonal | n2=en:no immune defects reported | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:normal numbers of cd56+ natural killer cells
n1=en:increased igm levels, polyclonal | n2=en:normal numbers of cd56+ natural killer cells | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:normal numbers of immune cells
n1=en:increased igm levels, polyclonal | n2=en:normal numbers of immune cells | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:normal or increased numbers of transitional b cells
n1=en:increased igm levels, polyclonal | n2=en:normal or increased numbers of transitional b cells | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:nut hypersensitivity
n1=en:increased igm levels, polyclonal | n2=en:nut hypersensitivity | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:poor adhesion related functions, such as adhesion to endothelial cells, chemotaxis, and antibody-dependent cellular cytotoxicity
n1=en:increased igm levels, polyclonal | n2=en:poor adhesion related functions, such as adhesion to endothelial cells, chemotaxis, and antibody-dependent cellular cytotoxicity | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:presence of c3 nephritic factor autoantibody
n1=en:increased igm levels, polyclonal | n2=en:presence of c3 nephritic factor autoantibody | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:progressive loss of antibodies
n1=en:increased igm levels, polyclonal | n2=en:progressive loss of antibodies | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:recurrent cutaneous mycoses
n1=en:increased igm levels, polyclonal | n2=en:recurrent cutaneous mycoses | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:recurrent fungal infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent fungal infections | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:recurrent infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:recurrent meningococcal disease
n1=en:increased igm levels, polyclonal | n2=en:recurrent meningococcal disease | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:recurrent severe and invasive bacterial infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent severe and invasive bacterial infections | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:recurrent sinopulmonary infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent sinopulmonary infections | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:reduced levels of cells with igm receptors
n1=en:increased igm levels, polyclonal | n2=en:reduced levels of cells with igm receptors | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:septicemia
n1=en:increased igm levels, polyclonal | n2=en:septicemia | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:severe enteroviral infections
n1=en:increased igm levels, polyclonal | n2=en:severe enteroviral infections | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:t-cell dysfunction (1 patient)
n1=en:increased igm levels, polyclonal | n2=en:t-cell dysfunction (1 patient) | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:t-lymphocyte deficiency
n1=en:increased igm levels, polyclonal | n2=en:t-lymphocyte deficiency | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:usually precipitated by viral infection (influenza a, influenza b, parainfluenza ii, and mycoplasma pneumoniae)
n1=en:increased igm levels, polyclonal | n2=en:usually precipitated by viral infection (influenza a, influenza b, parainfluenza ii, and mycoplasma pneumoniae) | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 31 / 0.721 ->
en:variable deficit of tissue macrophages
n1=en:increased igm levels, polyclonal | n2=en:variable deficit of tissue macrophages | rel=r_associated | relid=0 | w=31
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:absent microvilli on the surface of peripheral blood lymphocytes
n1=en:increased igm levels, polyclonal | n2=en:absent microvilli on the surface of peripheral blood lymphocytes | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:absent natural killer cell cytotoxicity
n1=en:increased igm levels, polyclonal | n2=en:absent natural killer cell cytotoxicity | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:absent sialyl-lewis x ligand (slex) expression
n1=en:increased igm levels, polyclonal | n2=en:absent sialyl-lewis x ligand (slex) expression | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:activated mononuclear phagocytes
n1=en:increased igm levels, polyclonal | n2=en:activated mononuclear phagocytes | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:allergy to eggs
n1=en:increased igm levels, polyclonal | n2=en:allergy to eggs | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:antibodies
n1=en:increased igm levels, polyclonal | n2=en:antibodies | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:antinuclear antibody present, speckled pattern
n1=en:increased igm levels, polyclonal | n2=en:antinuclear antibody present, speckled pattern | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:autoinflammation
n1=en:increased igm levels, polyclonal | n2=en:autoinflammation | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:autoinflammatory disorders
n1=en:increased igm levels, polyclonal | n2=en:autoinflammatory disorders | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:b and t cell defects (reported in 2 sibs)
n1=en:increased igm levels, polyclonal | n2=en:b and t cell defects (reported in 2 sibs) | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:bone marrow shows deficient granulopoiesis
n1=en:increased igm levels, polyclonal | n2=en:bone marrow shows deficient granulopoiesis | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:circulating immune complexes
n1=en:increased igm levels, polyclonal | n2=en:circulating immune complexes | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:clinical immunology
n1=en:increased igm levels, polyclonal | n2=en:clinical immunology | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:decreased cd8+ t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased cd8+ t cells | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:decreased differentiated b cells
n1=en:increased igm levels, polyclonal | n2=en:decreased differentiated b cells | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:decreased effector t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased effector t cells | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:decreased itk protein in lymphoid tissue
n1=en:increased igm levels, polyclonal | n2=en:decreased itk protein in lymphoid tissue | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:decreased lymphocyte apoptosis
n1=en:increased igm levels, polyclonal | n2=en:decreased lymphocyte apoptosis | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:decreased memory t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased memory t cells | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:decreased neutrophil and monocyte migration and chemotaxis
n1=en:increased igm levels, polyclonal | n2=en:decreased neutrophil and monocyte migration and chemotaxis | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:decreased or absent beta-2-microglobulin
n1=en:increased igm levels, polyclonal | n2=en:decreased or absent beta-2-microglobulin | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:decreased t cell-dependent antibody production
n1=en:increased igm levels, polyclonal | n2=en:decreased t cell-dependent antibody production | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:defective b cell differentiation
n1=en:increased igm levels, polyclonal | n2=en:defective b cell differentiation | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:defective generation of somatic hypermutations (shm)
n1=en:increased igm levels, polyclonal | n2=en:defective generation of somatic hypermutations (shm) | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:defective neutrophil function
n1=en:increased igm levels, polyclonal | n2=en:defective neutrophil function | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:defective t cell function
n1=en:increased igm levels, polyclonal | n2=en:defective t cell function | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:defective t-cell proliferative responses
n1=en:increased igm levels, polyclonal | n2=en:defective t-cell proliferative responses | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:environmental illness
n1=en:increased igm levels, polyclonal | n2=en:environmental illness | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:frequent bacterial, fungal and viral infections
n1=en:increased igm levels, polyclonal | n2=en:frequent bacterial, fungal and viral infections | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:frequent bacterial, viral, and opportunistic infections
n1=en:increased igm levels, polyclonal | n2=en:frequent bacterial, viral, and opportunistic infections | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:frequent fungal, viral, and opportunistic infections
n1=en:increased igm levels, polyclonal | n2=en:frequent fungal, viral, and opportunistic infections | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:frequent illnesses
n1=en:increased igm levels, polyclonal | n2=en:frequent illnesses | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:histology shows large regions of necrosis in lymph nodes, thymus, bone marrow, and spleen
n1=en:increased igm levels, polyclonal | n2=en:histology shows large regions of necrosis in lymph nodes, thymus, bone marrow, and spleen | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:immune dysregulation
n1=en:increased igm levels, polyclonal | n2=en:immune dysregulation | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:immune response
n1=en:increased igm levels, polyclonal | n2=en:immune response | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:impaired production of il17
n1=en:increased igm levels, polyclonal | n2=en:impaired production of il17 | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:increased ige level
n1=en:increased igm levels, polyclonal | n2=en:increased ige level | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:increased number of cd4(-)cd8(-)tcr-alpha-beta(+) t cells
n1=en:increased igm levels, polyclonal | n2=en:increased number of cd4(-)cd8(-)tcr-alpha-beta(+) t cells | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:increased percentage of naive igd+ igm+ cd27- b cells
n1=en:increased igm levels, polyclonal | n2=en:increased percentage of naive igd+ igm+ cd27- b cells | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:increased susceptibility to certain viral infections
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to certain viral infections | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:increased susceptibility to neisseria infections
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to neisseria infections | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:lack of circulating monocytes
n1=en:increased igm levels, polyclonal | n2=en:lack of circulating monocytes | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:lack of thymus on ultrasound
n1=en:increased igm levels, polyclonal | n2=en:lack of thymus on ultrasound | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:loss of or marked reduction of v(d)j recombination activity
n1=en:increased igm levels, polyclonal | n2=en:loss of or marked reduction of v(d)j recombination activity | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:low levels of antibodies to s. pneumoniae, h. influenzae type b
n1=en:increased igm levels, polyclonal | n2=en:low levels of antibodies to s. pneumoniae, h. influenzae type b | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:low t-cell function
n1=en:increased igm levels, polyclonal | n2=en:low t-cell function | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:lymphadenopathy subsequent to bcg vaccination
n1=en:increased igm levels, polyclonal | n2=en:lymphadenopathy subsequent to bcg vaccination | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:lymphopenia
n1=en:increased igm levels, polyclonal | n2=en:lymphopenia | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:marked reduction in cd4+/cd8+ ratio (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:marked reduction in cd4+/cd8+ ratio (in some patients) | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:no antibodies to intrinsic factor
n1=en:increased igm levels, polyclonal | n2=en:no antibodies to intrinsic factor | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:no evidence of prenatal infection
n1=en:increased igm levels, polyclonal | n2=en:no evidence of prenatal infection | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:normal numbers of absolute b cells
n1=en:increased igm levels, polyclonal | n2=en:normal numbers of absolute b cells | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:normal or elevated numbers of functional natural killer cells (nk)
n1=en:increased igm levels, polyclonal | n2=en:normal or elevated numbers of functional natural killer cells (nk) | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:normal serum immunoglobulin levels
n1=en:increased igm levels, polyclonal | n2=en:normal serum immunoglobulin levels | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:partial t-cell lymphopenia
n1=en:increased igm levels, polyclonal | n2=en:partial t-cell lymphopenia | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:patient cells show no gamma-interferon response to il12
n1=en:increased igm levels, polyclonal | n2=en:patient cells show no gamma-interferon response to il12 | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:peripheral lymphopenia
n1=en:increased igm levels, polyclonal | n2=en:peripheral lymphopenia | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:persistent polyclonal b-cell lymphocytosis
n1=en:increased igm levels, polyclonal | n2=en:persistent polyclonal b-cell lymphocytosis | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:polyclonal b-cell lymphocytosis
n1=en:increased igm levels, polyclonal | n2=en:polyclonal b-cell lymphocytosis | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:precipitated by infection (influenza a, influenza b, mycoplasma, hhv6)
n1=en:increased igm levels, polyclonal | n2=en:precipitated by infection (influenza a, influenza b, mycoplasma, hhv6) | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:recurrent fevers
n1=en:increased igm levels, polyclonal | n2=en:recurrent fevers | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:recurrent infections, bacterial and fungal
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections, bacterial and fungal | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:recurrent respiratory infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent respiratory infections | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:reduced delayed hypersensitivity
n1=en:increased igm levels, polyclonal | n2=en:reduced delayed hypersensitivity | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:sarcoidosis (in rare mutation carriers unaffected by hematologic malignancy)
n1=en:increased igm levels, polyclonal | n2=en:sarcoidosis (in rare mutation carriers unaffected by hematologic malignancy) | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:serum autoantibodies
n1=en:increased igm levels, polyclonal | n2=en:serum autoantibodies | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:severe combined immunodeficiency
n1=en:increased igm levels, polyclonal | n2=en:severe combined immunodeficiency | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:skin anergy to recall antigens
n1=en:increased igm levels, polyclonal | n2=en:skin anergy to recall antigens | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:small or absent thymus, which contains poorly formed hassal corpuscles
n1=en:increased igm levels, polyclonal | n2=en:small or absent thymus, which contains poorly formed hassal corpuscles | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:some patients may have autoantibodies to factor h, resulting in functional factor h deficiency
n1=en:increased igm levels, polyclonal | n2=en:some patients may have autoantibodies to factor h, resulting in functional factor h deficiency | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:specific antibody production very poor
n1=en:increased igm levels, polyclonal | n2=en:specific antibody production very poor | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:susceptibility to infection with influenza a infection
n1=en:increased igm levels, polyclonal | n2=en:susceptibility to infection with influenza a infection | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 30 / 0.698 ->
en:t-cell dysfunction, variable (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:t-cell dysfunction, variable (in some patients) | rel=r_associated | relid=0 | w=30
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:abnormality of t cells
n1=en:increased igm levels, polyclonal | n2=en:abnormality of t cells | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:absence of humoral and cellular immune response to foreign antigens
n1=en:increased igm levels, polyclonal | n2=en:absence of humoral and cellular immune response to foreign antigens | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:absent antibody production
n1=en:increased igm levels, polyclonal | n2=en:absent antibody production | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:absent peripheral blood t cells
n1=en:increased igm levels, polyclonal | n2=en:absent peripheral blood t cells | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:activated hla dr+ t cells in peripheral blood
n1=en:increased igm levels, polyclonal | n2=en:activated hla dr+ t cells in peripheral blood | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:allergic to dogs
n1=en:increased igm levels, polyclonal | n2=en:allergic to dogs | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:alpha/beta, cd4-/cd8- t cells are minimally or not increased
n1=en:increased igm levels, polyclonal | n2=en:alpha/beta, cd4-/cd8- t cells are minimally or not increased | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:antinuclear autoantibodies (in some)
n1=en:increased igm levels, polyclonal | n2=en:antinuclear autoantibodies (in some) | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:armed macrophage
n1=en:increased igm levels, polyclonal | n2=en:armed macrophage | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:arthritis
n1=en:increased igm levels, polyclonal | n2=en:arthritis | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:atopic disorders (eczema, food allergy, asthma)
n1=en:increased igm levels, polyclonal | n2=en:atopic disorders (eczema, food allergy, asthma) | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:autoimmune disease resembling systemic lupus erythematosus (sle, 152700) (in about 26%)
n1=en:increased igm levels, polyclonal | n2=en:autoimmune disease resembling systemic lupus erythematosus (sle, 152700) (in about 26%) | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:b cells lack surface cd19 and cd81 expression
n1=en:increased igm levels, polyclonal | n2=en:b cells lack surface cd19 and cd81 expression | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:biopsy shows lipid-laden macrophages
n1=en:increased igm levels, polyclonal | n2=en:biopsy shows lipid-laden macrophages | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:burkholderia cepacia infection
n1=en:increased igm levels, polyclonal | n2=en:burkholderia cepacia infection | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:combined variable immunodeficiency
n1=en:increased igm levels, polyclonal | n2=en:combined variable immunodeficiency | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:continuous activation of the alternative complement pathway
n1=en:increased igm levels, polyclonal | n2=en:continuous activation of the alternative complement pathway | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:decreased cd3 complex
n1=en:increased igm levels, polyclonal | n2=en:decreased cd3 complex | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:decreased cytotoxic t cell activity
n1=en:increased igm levels, polyclonal | n2=en:decreased cytotoxic t cell activity | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:decreased lymphatic tissue (tonsil, thymus, mesenteric nodes, peyer patches)
n1=en:increased igm levels, polyclonal | n2=en:decreased lymphatic tissue (tonsil, thymus, mesenteric nodes, peyer patches) | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:decreased memory b cells, progressive
n1=en:increased igm levels, polyclonal | n2=en:decreased memory b cells, progressive | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:decreased natural killer t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased natural killer t cells | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:decreased number of cd8+ t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased number of cd8+ t cells | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:decreased t cell response to mitogens
n1=en:increased igm levels, polyclonal | n2=en:decreased t cell response to mitogens | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:defective cd95-induced apoptosis of peripheral blood lymphocytes
n1=en:increased igm levels, polyclonal | n2=en:defective cd95-induced apoptosis of peripheral blood lymphocytes | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:depletion of components of the alternative complement pathway
n1=en:increased igm levels, polyclonal | n2=en:depletion of components of the alternative complement pathway | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:developmental arrest of b cells at the pre-b to pro-b cell transition stage
n1=en:increased igm levels, polyclonal | n2=en:developmental arrest of b cells at the pre-b to pro-b cell transition stage | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:developmental immunology
n1=en:increased igm levels, polyclonal | n2=en:developmental immunology | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:dysgammaglobulinemia
n1=en:increased igm levels, polyclonal | n2=en:dysgammaglobulinemia | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:hemophagocytosis in bone marrow, lymph nodes, spleen, liver, and central nervous system
n1=en:increased igm levels, polyclonal | n2=en:hemophagocytosis in bone marrow, lymph nodes, spleen, liver, and central nervous system | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:hypereosinophilia
n1=en:increased igm levels, polyclonal | n2=en:hypereosinophilia | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:hypergammaglobulinemia (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:hypergammaglobulinemia (in some patients) | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:hyperinflammatory state
n1=en:increased igm levels, polyclonal | n2=en:hyperinflammatory state | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:hypocomplementemia (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:hypocomplementemia (in some patients) | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:hypoimmunoglobulinemia
n1=en:increased igm levels, polyclonal | n2=en:hypoimmunoglobulinemia | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:immunodeficiency, primarily affecting b cell line
n1=en:increased igm levels, polyclonal | n2=en:immunodeficiency, primarily affecting b cell line | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:immunoglobulin a deficiency (disorder)
n1=en:increased igm levels, polyclonal | n2=en:immunoglobulin a deficiency (disorder) | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:impaired antiviral response to alpha- and beta-interferon signaling
n1=en:increased igm levels, polyclonal | n2=en:impaired antiviral response to alpha- and beta-interferon signaling | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:impaired b cell class-switching
n1=en:increased igm levels, polyclonal | n2=en:impaired b cell class-switching | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:impaired seroconversion of immunoglobulins in response to vaccination
n1=en:increased igm levels, polyclonal | n2=en:impaired seroconversion of immunoglobulins in response to vaccination | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:increase in proinflammatory chemokines
n1=en:increased igm levels, polyclonal | n2=en:increase in proinflammatory chemokines | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:increase in tlr2+ (603028)/tlr4- (603030) granulocytes
n1=en:increased igm levels, polyclonal | n2=en:increase in tlr2+ (603028)/tlr4- (603030) granulocytes | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:increased frequency of bacterial, viral, and fungal infections
n1=en:increased igm levels, polyclonal | n2=en:increased frequency of bacterial, viral, and fungal infections | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:increased nonspecific cd8+ t-cell proliferation
n1=en:increased igm levels, polyclonal | n2=en:increased nonspecific cd8+ t-cell proliferation | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:increased serum igm (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:increased serum igm (in some patients) | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:increased susceptibility to haemophilus influenzae infections
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to haemophilus influenzae infections | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:increased susceptibility to herpes encephalitis
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to herpes encephalitis | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:increased susceptibility to virus (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to virus (in some patients) | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:increased total number of cd19+ b cells
n1=en:increased igm levels, polyclonal | n2=en:increased total number of cd19+ b cells | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:lack of peripheral cd3+ t cells
n1=en:increased igm levels, polyclonal | n2=en:lack of peripheral cd3+ t cells | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:leukopenia
n1=en:increased igm levels, polyclonal | n2=en:leukopenia | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:low memory b cells
n1=en:increased igm levels, polyclonal | n2=en:low memory b cells | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:low t cells
n1=en:increased igm levels, polyclonal | n2=en:low t cells | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:lymph nodes are small and poorly developed
n1=en:increased igm levels, polyclonal | n2=en:lymph nodes are small and poorly developed | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:maturational arrest of granulocytes at the promyelocyte/myelocyte stage seen on bone marrow biopsy
n1=en:increased igm levels, polyclonal | n2=en:maturational arrest of granulocytes at the promyelocyte/myelocyte stage seen on bone marrow biopsy | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:nk cells showed unusual surface cd16 antibody reactions
n1=en:increased igm levels, polyclonal | n2=en:nk cells showed unusual surface cd16 antibody reactions | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:normal numbers of lymphocytes
n1=en:increased igm levels, polyclonal | n2=en:normal numbers of lymphocytes | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:normal numbers of lymphocytes and nk cells
n1=en:increased igm levels, polyclonal | n2=en:normal numbers of lymphocytes and nk cells | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:normal or decreased numbers of circulating b cells
n1=en:increased igm levels, polyclonal | n2=en:normal or decreased numbers of circulating b cells | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:normal response to bacterial antigens
n1=en:increased igm levels, polyclonal | n2=en:normal response to bacterial antigens | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:normal-elevated igm
n1=en:increased igm levels, polyclonal | n2=en:normal-elevated igm | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:papillomavirus infections
n1=en:increased igm levels, polyclonal | n2=en:papillomavirus infections | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:periodic fevers (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:periodic fevers (in some patients) | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:polymorphic b cell lymphoproliferation
n1=en:increased igm levels, polyclonal | n2=en:polymorphic b cell lymphoproliferation | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:poor differentiation and proliferation of b and t cells
n1=en:increased igm levels, polyclonal | n2=en:poor differentiation and proliferation of b and t cells | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:poor t-cell mitogen response
n1=en:increased igm levels, polyclonal | n2=en:poor t-cell mitogen response | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:recurrent bacterial infection
n1=en:increased igm levels, polyclonal | n2=en:recurrent bacterial infection | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:recurrent bacterial skin infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent bacterial skin infections | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:recurrent infections (1 patient)
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections (1 patient) | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:recurrent infections (pneumonia, sinusitis, fulminant varicella)
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections (pneumonia, sinusitis, fulminant varicella) | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:reduced numbers of memory b cells
n1=en:increased igm levels, polyclonal | n2=en:reduced numbers of memory b cells | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:sepsis
n1=en:increased igm levels, polyclonal | n2=en:sepsis | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:serum immunoglobulins may be absent, normal, or increased
n1=en:increased igm levels, polyclonal | n2=en:serum immunoglobulins may be absent, normal, or increased | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:severe b lymphocytopenia
n1=en:increased igm levels, polyclonal | n2=en:severe b lymphocytopenia | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:severely reduced proliferative response to mitogens, antigens, and alloantigens
n1=en:increased igm levels, polyclonal | n2=en:severely reduced proliferative response to mitogens, antigens, and alloantigens | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:slightly reduced neutrophil adherence
n1=en:increased igm levels, polyclonal | n2=en:slightly reduced neutrophil adherence | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:transplantation immunology
n1=en:increased igm levels, polyclonal | n2=en:transplantation immunology | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 29 / 0.674 ->
en:very low lymphocyte proliferation in response to mitogens and alloantigens
n1=en:increased igm levels, polyclonal | n2=en:very low lymphocyte proliferation in response to mitogens and alloantigens | rel=r_associated | relid=0 | w=29
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:abnormal immunoglobulin level
n1=en:increased igm levels, polyclonal | n2=en:abnormal immunoglobulin level | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:abscesses are 'cold,' lacking erythema, heat, and swelling
n1=en:increased igm levels, polyclonal | n2=en:abscesses are 'cold,' lacking erythema, heat, and swelling | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:absence of lymph nodes (in 1 patient)
n1=en:increased igm levels, polyclonal | n2=en:absence of lymph nodes (in 1 patient) | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:absent b lymphocytes in all organs
n1=en:increased igm levels, polyclonal | n2=en:absent b lymphocytes in all organs | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:absent mitogenic response
n1=en:increased igm levels, polyclonal | n2=en:absent mitogenic response | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:absent mucosal associated invariant t cells
n1=en:increased igm levels, polyclonal | n2=en:absent mucosal associated invariant t cells | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:absent plasma cells in all organs
n1=en:increased igm levels, polyclonal | n2=en:absent plasma cells in all organs | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:absent type 1 nk t cells
n1=en:increased igm levels, polyclonal | n2=en:absent type 1 nk t cells | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:antigenically defective c8 detected
n1=en:increased igm levels, polyclonal | n2=en:antigenically defective c8 detected | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:antigens
n1=en:increased igm levels, polyclonal | n2=en:antigens | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:associated with autoantibodies to gad65 (anti-glutamic acid decarboxylase gad2, 138275) in serum and/or cerebrospinal fluid
n1=en:increased igm levels, polyclonal | n2=en:associated with autoantibodies to gad65 (anti-glutamic acid decarboxylase gad2, 138275) in serum and/or cerebrospinal fluid | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:associated with serum autoantibodies to glra1 (glycine receptor alpha-1 subunit 138491, reported in 1 patient)
n1=en:increased igm levels, polyclonal | n2=en:associated with serum autoantibodies to glra1 (glycine receptor alpha-1 subunit 138491, reported in 1 patient) | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:asthma
n1=en:increased igm levels, polyclonal | n2=en:asthma | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:block of b-cell differentiation
n1=en:increased igm levels, polyclonal | n2=en:block of b-cell differentiation | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:c1q deficiency
n1=en:increased igm levels, polyclonal | n2=en:c1q deficiency | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:c2 deficiency
n1=en:increased igm levels, polyclonal | n2=en:c2 deficiency | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:candida albicans infections, chronic, recurrent
n1=en:increased igm levels, polyclonal | n2=en:candida albicans infections, chronic, recurrent | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:circulating t and b cells are naive
n1=en:increased igm levels, polyclonal | n2=en:circulating t and b cells are naive | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:combined humoral and cellular immunodeficiency
n1=en:increased igm levels, polyclonal | n2=en:combined humoral and cellular immunodeficiency | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:combined immunodeficiency (reported in 1 patient)
n1=en:increased igm levels, polyclonal | n2=en:combined immunodeficiency (reported in 1 patient) | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:decreased cd3(-)cd16/15(+) natural killer cells
n1=en:increased igm levels, polyclonal | n2=en:decreased cd3(-)cd16/15(+) natural killer cells | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:decreased circulating b cells (total cd19+)
n1=en:increased igm levels, polyclonal | n2=en:decreased circulating b cells (total cd19+) | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:decreased circulating cd4+ t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased circulating cd4+ t cells | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:decreased immunoglobulin g (igg)
n1=en:increased igm levels, polyclonal | n2=en:decreased immunoglobulin g (igg) | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:decreased naive cd4+ and cd8+ t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased naive cd4+ and cd8+ t cells | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:decreased number of cd4+ t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased number of cd4+ t cells | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:decreased numbers of nk cells
n1=en:increased igm levels, polyclonal | n2=en:decreased numbers of nk cells | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:decreased regulatory t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased regulatory t cells | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:decreased serum igg and igm
n1=en:increased igm levels, polyclonal | n2=en:decreased serum igg and igm | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:defective antibody production, particularly t-cell-independent
n1=en:increased igm levels, polyclonal | n2=en:defective antibody production, particularly t-cell-independent | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:defective antigen-specific skin response
n1=en:increased igm levels, polyclonal | n2=en:defective antigen-specific skin response | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:erythrophagocytosis in late phase
n1=en:increased igm levels, polyclonal | n2=en:erythrophagocytosis in late phase | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:few mature neutrophils in the bone marrow
n1=en:increased igm levels, polyclonal | n2=en:few mature neutrophils in the bone marrow | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:food allergies (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:food allergies (in some patients) | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:hashimoto disease
n1=en:increased igm levels, polyclonal | n2=en:hashimoto disease | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:henoch-schoenlein purpura
n1=en:increased igm levels, polyclonal | n2=en:henoch-schoenlein purpura | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:herpesviridae infections
n1=en:increased igm levels, polyclonal | n2=en:herpesviridae infections | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:humoral deficiency (likely result of t-cell abnormalities)
n1=en:increased igm levels, polyclonal | n2=en:humoral deficiency (likely result of t-cell abnormalities) | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:immune deficiency (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:immune deficiency (in some patients) | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:immune disorder (in rare mutations carriers unaffected by a hematologic malignancy)
n1=en:increased igm levels, polyclonal | n2=en:immune disorder (in rare mutations carriers unaffected by a hematologic malignancy) | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:immunodeficiency (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:immunodeficiency (in some patients) | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:immunodeficiency, severe combined (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:immunodeficiency, severe combined (in some patients) | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:impaired nk cell degranulation (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:impaired nk cell degranulation (in some patients) | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:impaired signaling through the t-cell receptor
n1=en:increased igm levels, polyclonal | n2=en:impaired signaling through the t-cell receptor | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:impaired t cell proliferative response
n1=en:increased igm levels, polyclonal | n2=en:impaired t cell proliferative response | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:inability to reject allogenic cells
n1=en:increased igm levels, polyclonal | n2=en:inability to reject allogenic cells | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:increased effector cd8+ t cells
n1=en:increased igm levels, polyclonal | n2=en:increased effector cd8+ t cells | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:increased levels of t cells bearing gamma/delta antigen receptor
n1=en:increased igm levels, polyclonal | n2=en:increased levels of t cells bearing gamma/delta antigen receptor | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:increased serum ige
n1=en:increased igm levels, polyclonal | n2=en:increased serum ige | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:increased susceptibility to pneumocystis and cytomegalovirus infections
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to pneumocystis and cytomegalovirus infections | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:increased susceptibility to severe and frequent infections with staphylococcus aureus
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to severe and frequent infections with staphylococcus aureus | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:isolated absence of cd8+ t cells
n1=en:increased igm levels, polyclonal | n2=en:isolated absence of cd8+ t cells | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:kappa-chain deficiency
n1=en:increased igm levels, polyclonal | n2=en:kappa-chain deficiency | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:lack of autoantibodies
n1=en:increased igm levels, polyclonal | n2=en:lack of autoantibodies | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:lymphadenitis
n1=en:increased igm levels, polyclonal | n2=en:lymphadenitis | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:lymphohistiocytic infiltration and hemophagocytosis in multiple organs
n1=en:increased igm levels, polyclonal | n2=en:lymphohistiocytic infiltration and hemophagocytosis in multiple organs | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:lymphopenia (1 family)
n1=en:increased igm levels, polyclonal | n2=en:lymphopenia (1 family) | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:markedly elevated ige
n1=en:increased igm levels, polyclonal | n2=en:markedly elevated ige | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:markedly reduced numbers of natural killer cells
n1=en:increased igm levels, polyclonal | n2=en:markedly reduced numbers of natural killer cells | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:neutrophils show disorganized lysosomal compartments on ultrastructural analysis
n1=en:increased igm levels, polyclonal | n2=en:neutrophils show disorganized lysosomal compartments on ultrastructural analysis | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:no evidence of common prenatal infections
n1=en:increased igm levels, polyclonal | n2=en:no evidence of common prenatal infections | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:no immunologic abnormalities
n1=en:increased igm levels, polyclonal | n2=en:no immunologic abnormalities | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:normal activity of natural killer cells
n1=en:increased igm levels, polyclonal | n2=en:normal activity of natural killer cells | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:normal b-cell count
n1=en:increased igm levels, polyclonal | n2=en:normal b-cell count | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:normal numbers of t and b cells
n1=en:increased igm levels, polyclonal | n2=en:normal numbers of t and b cells | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:normal titers to t cell-dependent vaccines
n1=en:increased igm levels, polyclonal | n2=en:normal titers to t cell-dependent vaccines | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:opportunistic infections (cmv, pneumocystis, candida)
n1=en:increased igm levels, polyclonal | n2=en:opportunistic infections (cmv, pneumocystis, candida) | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:opportunistic infections include nocardia asteroides and mycobacterium avium complex
n1=en:increased igm levels, polyclonal | n2=en:opportunistic infections include nocardia asteroides and mycobacterium avium complex | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:poor production of certain cytokines (il-12, gamma-interferon, il-10, il-6, tnf-alpha) after stimulation
n1=en:increased igm levels, polyclonal | n2=en:poor production of certain cytokines (il-12, gamma-interferon, il-10, il-6, tnf-alpha) after stimulation | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:positive antinuclear autoantibodies
n1=en:increased igm levels, polyclonal | n2=en:positive antinuclear autoantibodies | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:recurrent infections (enteritis, otitis, and urinary infection)
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections (enteritis, otitis, and urinary infection) | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:recurrent infections (increased susceptibility to mycobacterial infection after bcg immunization)
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections (increased susceptibility to mycobacterial infection after bcg immunization) | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:recurrent neisserial infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent neisserial infections | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:reduced cd4+ t cells
n1=en:increased igm levels, polyclonal | n2=en:reduced cd4+ t cells | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:reduced t cell cytotoxicity
n1=en:increased igm levels, polyclonal | n2=en:reduced t cell cytotoxicity | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:selective iga immunodeficiency
n1=en:increased igm levels, polyclonal | n2=en:selective iga immunodeficiency | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:serum circulating immune complexes contain galactose-deficient iga1
n1=en:increased igm levels, polyclonal | n2=en:serum circulating immune complexes contain galactose-deficient iga1 | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:staphylococcus aureus infection
n1=en:increased igm levels, polyclonal | n2=en:staphylococcus aureus infection | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:susceptibility to mycobacterial disease
n1=en:increased igm levels, polyclonal | n2=en:susceptibility to mycobacterial disease | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:t cell defect, mild to severe
n1=en:increased igm levels, polyclonal | n2=en:t cell defect, mild to severe | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:t-cell lymphopenia
n1=en:increased igm levels, polyclonal | n2=en:t-cell lymphopenia | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:thymic hypoplasia or aplasia
n1=en:increased igm levels, polyclonal | n2=en:thymic hypoplasia or aplasia | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 28 / 0.651 ->
en:undetectable igm and iga
n1=en:increased igm levels, polyclonal | n2=en:undetectable igm and iga | rel=r_associated | relid=0 | w=28
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:abscess formation in any organ
n1=en:increased igm levels, polyclonal | n2=en:abscess formation in any organ | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:absence of acetylcholine receptor (achr) autoantibodies
n1=en:increased igm levels, polyclonal | n2=en:absence of acetylcholine receptor (achr) autoantibodies | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:absent cd8+ t cells
n1=en:increased igm levels, polyclonal | n2=en:absent cd8+ t cells | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:absent humoral immunity
n1=en:increased igm levels, polyclonal | n2=en:absent humoral immunity | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:absent specific antibody response
n1=en:increased igm levels, polyclonal | n2=en:absent specific antibody response | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:antinuclear antibody present (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:antinuclear antibody present (in some patients) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:aspergillus infections
n1=en:increased igm levels, polyclonal | n2=en:aspergillus infections | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:b cells lack surface cd20 expression
n1=en:increased igm levels, polyclonal | n2=en:b cells lack surface cd20 expression | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:b-cell lymphocytosis
n1=en:increased igm levels, polyclonal | n2=en:b-cell lymphocytosis | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:bone marrow shows lymphoid hyperplasia
n1=en:increased igm levels, polyclonal | n2=en:bone marrow shows lymphoid hyperplasia | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:cd4+ t-cell lymphopenia
n1=en:increased igm levels, polyclonal | n2=en:cd4+ t-cell lymphopenia | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:chronic human papillomavirus (hpv) infection
n1=en:increased igm levels, polyclonal | n2=en:chronic human papillomavirus (hpv) infection | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:combined variable immunodeficiency involving b and t cells
n1=en:increased igm levels, polyclonal | n2=en:combined variable immunodeficiency involving b and t cells | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:decreased alpha-beta cd8+ t cells (family b)
n1=en:increased igm levels, polyclonal | n2=en:decreased alpha-beta cd8+ t cells (family b) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:decreased b cells
n1=en:increased igm levels, polyclonal | n2=en:decreased b cells | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:decreased cd8+ cells subset
n1=en:increased igm levels, polyclonal | n2=en:decreased cd8+ cells subset | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:decreased circulating class-switched memory b cells (cd19+cd27+igd-)
n1=en:increased igm levels, polyclonal | n2=en:decreased circulating class-switched memory b cells (cd19+cd27+igd-) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:decreased expression of neonatal fc receptor
n1=en:increased igm levels, polyclonal | n2=en:decreased expression of neonatal fc receptor | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:decreased numbers of mature b cells
n1=en:increased igm levels, polyclonal | n2=en:decreased numbers of mature b cells | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:decreased numbers of thymus emigrant cells
n1=en:increased igm levels, polyclonal | n2=en:decreased numbers of thymus emigrant cells | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:decreased serum complement c3 (120700)
n1=en:increased igm levels, polyclonal | n2=en:decreased serum complement c3 (120700) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:decreased serum complement factor b (cfb, 138470)
n1=en:increased igm levels, polyclonal | n2=en:decreased serum complement factor b (cfb, 138470) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:decreased serum iga
n1=en:increased igm levels, polyclonal | n2=en:decreased serum iga | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:defect in b-cell differentiation
n1=en:increased igm levels, polyclonal | n2=en:defect in b-cell differentiation | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:defective cd8+ t cell function
n1=en:increased igm levels, polyclonal | n2=en:defective cd8+ t cell function | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:defective complement regulation
n1=en:increased igm levels, polyclonal | n2=en:defective complement regulation | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:depleted cd4+ t cells
n1=en:increased igm levels, polyclonal | n2=en:depleted cd4+ t cells | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:dermatomyositis (in 1 patient)
n1=en:increased igm levels, polyclonal | n2=en:dermatomyositis (in 1 patient) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:elevated il8 (146930)
n1=en:increased igm levels, polyclonal | n2=en:elevated il8 (146930) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:elevated polyclonal igd (equal to or greater than 100 iu/ml)
n1=en:increased igm levels, polyclonal | n2=en:elevated polyclonal igd (equal to or greater than 100 iu/ml) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:foot infections leading to amputation
n1=en:increased igm levels, polyclonal | n2=en:foot infections leading to amputation | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:granulocyte dysfunction (1 patient)
n1=en:increased igm levels, polyclonal | n2=en:granulocyte dysfunction (1 patient) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:granulomas, non-infectious
n1=en:increased igm levels, polyclonal | n2=en:granulomas, non-infectious | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:igm deficiency
n1=en:increased igm levels, polyclonal | n2=en:igm deficiency | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:il6 continuously elevated (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:il6 continuously elevated (in some patients) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:immunogenetics
n1=en:increased igm levels, polyclonal | n2=en:immunogenetics | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:immunology
n1=en:increased igm levels, polyclonal | n2=en:immunology | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:impaired b cell memory cells
n1=en:increased igm levels, polyclonal | n2=en:impaired b cell memory cells | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:increase in b cells (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:increase in b cells (in some patients) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:increased cd21+ (low) b cells
n1=en:increased igm levels, polyclonal | n2=en:increased cd21+ (low) b cells | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:increased iga level
n1=en:increased igm levels, polyclonal | n2=en:increased iga level | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:increased percentage of naive b cells
n1=en:increased igm levels, polyclonal | n2=en:increased percentage of naive b cells | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:increased proportion of hla dr+ and cd57+ t cells
n1=en:increased igm levels, polyclonal | n2=en:increased proportion of hla dr+ and cd57+ t cells | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:increased susceptibility to mycobacterial infections
n1=en:increased igm levels, polyclonal | n2=en:increased susceptibility to mycobacterial infections | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:intrinsic b cell defect
n1=en:increased igm levels, polyclonal | n2=en:intrinsic b cell defect | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:lack of peripheral lymphoid tissue
n1=en:increased igm levels, polyclonal | n2=en:lack of peripheral lymphoid tissue | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:low igg in adolescence (2 of 4 affected individuals)
n1=en:increased igm levels, polyclonal | n2=en:low igg in adolescence (2 of 4 affected individuals) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:low or normal serum immunoglobulins
n1=en:increased igm levels, polyclonal | n2=en:low or normal serum immunoglobulins | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:low to normal immunoglobulin levels
n1=en:increased igm levels, polyclonal | n2=en:low to normal immunoglobulin levels | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:low-absent igg, iga
n1=en:increased igm levels, polyclonal | n2=en:low-absent igg, iga | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:markedly elevated ige levels
n1=en:increased igm levels, polyclonal | n2=en:markedly elevated ige levels | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:monocytes show impaired motility
n1=en:increased igm levels, polyclonal | n2=en:monocytes show impaired motility | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:monocytosis
n1=en:increased igm levels, polyclonal | n2=en:monocytosis | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:natural killer t cell count decreased
n1=en:increased igm levels, polyclonal | n2=en:natural killer t cell count decreased | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:neonatal sepsis
n1=en:increased igm levels, polyclonal | n2=en:neonatal sepsis | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:neutropenia
n1=en:increased igm levels, polyclonal | n2=en:neutropenia | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:neutropenia (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:neutropenia (in some patients) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:no concurrent parasitic infection
n1=en:increased igm levels, polyclonal | n2=en:no concurrent parasitic infection | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:normal nk cells
n1=en:increased igm levels, polyclonal | n2=en:normal nk cells | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:normal numbers of cd19+ b-lymphocytes
n1=en:increased igm levels, polyclonal | n2=en:normal numbers of cd19+ b-lymphocytes | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:normal to elevated igg
n1=en:increased igm levels, polyclonal | n2=en:normal to elevated igg | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:often an infecting organism cannot be identified
n1=en:increased igm levels, polyclonal | n2=en:often an infecting organism cannot be identified | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:opportunistic infections
n1=en:increased igm levels, polyclonal | n2=en:opportunistic infections | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:overproduction by t lymphocytes and macrophages of cytokines, particularly interferon gamma and tumor necrosis factor alpha
n1=en:increased igm levels, polyclonal | n2=en:overproduction by t lymphocytes and macrophages of cytokines, particularly interferon gamma and tumor necrosis factor alpha | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:paucity of lymphoid tissue
n1=en:increased igm levels, polyclonal | n2=en:paucity of lymphoid tissue | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:polysaccharide antibody response defect
n1=en:increased igm levels, polyclonal | n2=en:polysaccharide antibody response defect | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:positive anti-nucleus antibodies
n1=en:increased igm levels, polyclonal | n2=en:positive anti-nucleus antibodies | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:present but small tonsils
n1=en:increased igm levels, polyclonal | n2=en:present but small tonsils | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:recurrent bacterial, viral, and fungal infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent bacterial, viral, and fungal infections | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:recurrent candida infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent candida infections | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:recurrent infections of mucosal surfaces
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections of mucosal surfaces | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:recurrent mycobacterial disease (bcg and m. tuberculosis)
n1=en:increased igm levels, polyclonal | n2=en:recurrent mycobacterial disease (bcg and m. tuberculosis) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:recurrent opportunistic infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent opportunistic infections | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:reduced cd3+, cd4+, and cd8+ t-lymphocytes
n1=en:increased igm levels, polyclonal | n2=en:reduced cd3+, cd4+, and cd8+ t-lymphocytes | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:reduced natural killer cell cytotoxicity
n1=en:increased igm levels, polyclonal | n2=en:reduced natural killer cell cytotoxicity | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:serum igg autoantibodies to granulocyte/macrophage colony-stimulating factor (gm-csf, csf2, 138960)
n1=en:increased igm levels, polyclonal | n2=en:serum igg autoantibodies to granulocyte/macrophage colony-stimulating factor (gm-csf, csf2, 138960) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:t cells may show impaired proliferative response to tetanus toxoid
n1=en:increased igm levels, polyclonal | n2=en:t cells may show impaired proliferative response to tetanus toxoid | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:t-cells show reduced cytotoxicity and reduced cytolytic granule exocytosis
n1=en:increased igm levels, polyclonal | n2=en:t-cells show reduced cytotoxicity and reduced cytolytic granule exocytosis | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:thymus hypoplasia (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:thymus hypoplasia (in some patients) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 27 / 0.628 ->
en:transient iga deficiency (1 patient)
n1=en:increased igm levels, polyclonal | n2=en:transient iga deficiency (1 patient) | rel=r_associated | relid=0 | w=27
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:absence of auto-antibodies to intrinsic factor or parietal cells
n1=en:increased igm levels, polyclonal | n2=en:absence of auto-antibodies to intrinsic factor or parietal cells | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:absence of cd3+ t cells (1 family)
n1=en:increased igm levels, polyclonal | n2=en:absence of cd3+ t cells (1 family) | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:absent or reduced cd3+ cells
n1=en:increased igm levels, polyclonal | n2=en:absent or reduced cd3+ cells | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:absolute lymphocyte count decreased
n1=en:increased igm levels, polyclonal | n2=en:absolute lymphocyte count decreased | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:angioedema
n1=en:increased igm levels, polyclonal | n2=en:angioedema | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:autoantibodies (anti-nuclear, anti-dsdna, anti-cardiolipin)
n1=en:increased igm levels, polyclonal | n2=en:autoantibodies (anti-nuclear, anti-dsdna, anti-cardiolipin) | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:autoimmune features (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:autoimmune features (in some patients) | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:b-cell lymphopenia
n1=en:increased igm levels, polyclonal | n2=en:b-cell lymphopenia | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:block at the pro-b to pre-b stage of differentiation
n1=en:increased igm levels, polyclonal | n2=en:block at the pro-b to pre-b stage of differentiation | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:cellular immunodeficiency
n1=en:increased igm levels, polyclonal | n2=en:cellular immunodeficiency | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:cellular immunology
n1=en:increased igm levels, polyclonal | n2=en:cellular immunology | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:chronic noninfectious lymphadenopathy
n1=en:increased igm levels, polyclonal | n2=en:chronic noninfectious lymphadenopathy | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:cutaneous anergy
n1=en:increased igm levels, polyclonal | n2=en:cutaneous anergy | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:decrease in granulocyte-specific cd16b (610665) isoform
n1=en:increased igm levels, polyclonal | n2=en:decrease in granulocyte-specific cd16b (610665) isoform | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:decreased cd4+cd45ra+ t cells
n1=en:increased igm levels, polyclonal | n2=en:decreased cd4+cd45ra+ t cells | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:decreased cell surface expression of mhc-i
n1=en:increased igm levels, polyclonal | n2=en:decreased cell surface expression of mhc-i | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:decreased circulating naive t cells (1 family)
n1=en:increased igm levels, polyclonal | n2=en:decreased circulating naive t cells (1 family) | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:decreased circulating nk cells
n1=en:increased igm levels, polyclonal | n2=en:decreased circulating nk cells | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:decreased igm and igg2
n1=en:increased igm levels, polyclonal | n2=en:decreased igm and igg2 | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:decreased nk cells (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:decreased nk cells (in some patients) | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:decreased or normal numbers of nk cells
n1=en:increased igm levels, polyclonal | n2=en:decreased or normal numbers of nk cells | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:decreased percentage of igd- igm- cd27+ class-switched memory b cells
n1=en:increased igm levels, polyclonal | n2=en:decreased percentage of igd- igm- cd27+ class-switched memory b cells | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:decreased percentage of igd+ igm+ cd27+ memory b cells
n1=en:increased igm levels, polyclonal | n2=en:decreased percentage of igd+ igm+ cd27+ memory b cells | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:decreased serum complement c3
n1=en:increased igm levels, polyclonal | n2=en:decreased serum complement c3 | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:decreased specific antibodies
n1=en:increased igm levels, polyclonal | n2=en:decreased specific antibodies | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:decreased t cell production of cytokines
n1=en:increased igm levels, polyclonal | n2=en:decreased t cell production of cytokines | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:defective b cell activation
n1=en:increased igm levels, polyclonal | n2=en:defective b cell activation | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:defective humoral response
n1=en:increased igm levels, polyclonal | n2=en:defective humoral response | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:defective il10 production by t cells
n1=en:increased igm levels, polyclonal | n2=en:defective il10 production by t cells | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:defective nk function in spontaneous cellular cytotoxicity
n1=en:increased igm levels, polyclonal | n2=en:defective nk function in spontaneous cellular cytotoxicity | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:dendritic cell cytopenia
n1=en:increased igm levels, polyclonal | n2=en:dendritic cell cytopenia | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:dermatophytic lymphadenitis (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:dermatophytic lymphadenitis (in some patients) | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:dysfunctional nk cells
n1=en:increased igm levels, polyclonal | n2=en:dysfunctional nk cells | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:ectopic thymus
n1=en:increased igm levels, polyclonal | n2=en:ectopic thymus | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:elevated iga (equal to or greater than 2.6g/l)
n1=en:increased igm levels, polyclonal | n2=en:elevated iga (equal to or greater than 2.6g/l) | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:elevated immunoglobulins, particularly ige
n1=en:increased igm levels, polyclonal | n2=en:elevated immunoglobulins, particularly ige | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:elevated levels of serum ige
n1=en:increased igm levels, polyclonal | n2=en:elevated levels of serum ige | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:fertility immunology
n1=en:increased igm levels, polyclonal | n2=en:fertility immunology | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:frequent infections t-lymphocyte dysfunction, rare
n1=en:increased igm levels, polyclonal | n2=en:frequent infections t-lymphocyte dysfunction, rare | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:generalized enlarged lymph nodes
n1=en:increased igm levels, polyclonal | n2=en:generalized enlarged lymph nodes | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:granulomas can appear on skin, tongue, lungs, or other tissues
n1=en:increased igm levels, polyclonal | n2=en:granulomas can appear on skin, tongue, lungs, or other tissues | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:hyper iga (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:hyper iga (in some patients) | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:hyperplasia of tonsils
n1=en:increased igm levels, polyclonal | n2=en:hyperplasia of tonsils | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:hypoglobulinemia result
n1=en:increased igm levels, polyclonal | n2=en:hypoglobulinemia result | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:hypoplastic thymus which often lacks hassal corpuscles
n1=en:increased igm levels, polyclonal | n2=en:hypoplastic thymus which often lacks hassal corpuscles | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:igg deficiency
n1=en:increased igm levels, polyclonal | n2=en:igg deficiency | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:immunophenotyping
n1=en:increased igm levels, polyclonal | n2=en:immunophenotyping | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:impaired t cell immunity
n1=en:increased igm levels, polyclonal | n2=en:impaired t cell immunity | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:increase in proinflammatory cytokines
n1=en:increased igm levels, polyclonal | n2=en:increase in proinflammatory cytokines | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:increased percentage of naive t cells
n1=en:increased igm levels, polyclonal | n2=en:increased percentage of naive t cells | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:klebsiella infections
n1=en:increased igm levels, polyclonal | n2=en:klebsiella infections | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:low nk cells
n1=en:increased igm levels, polyclonal | n2=en:low nk cells | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:lymph nodes show reactive follicular hyperplasia and non-caseating granulomas
n1=en:increased igm levels, polyclonal | n2=en:lymph nodes show reactive follicular hyperplasia and non-caseating granulomas | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:lymphadenopathy (cervical, inguinal, axillary)
n1=en:increased igm levels, polyclonal | n2=en:lymphadenopathy (cervical, inguinal, axillary) | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:lymphadenopathy in late phase
n1=en:increased igm levels, polyclonal | n2=en:lymphadenopathy in late phase | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:lymphadenopathy may occur
n1=en:increased igm levels, polyclonal | n2=en:lymphadenopathy may occur | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:lymphocyte count normal
n1=en:increased igm levels, polyclonal | n2=en:lymphocyte count normal | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:lymphopenia, progressive
n1=en:increased igm levels, polyclonal | n2=en:lymphopenia, progressive | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:mild to moderately reduced t cell count
n1=en:increased igm levels, polyclonal | n2=en:mild to moderately reduced t cell count | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:monocytopenia
n1=en:increased igm levels, polyclonal | n2=en:monocytopenia | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:natural killer cells, reduced numbers and cytotoxicity
n1=en:increased igm levels, polyclonal | n2=en:natural killer cells, reduced numbers and cytotoxicity | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:normal b cells
n1=en:increased igm levels, polyclonal | n2=en:normal b cells | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:normal or elevated lymphocytes
n1=en:increased igm levels, polyclonal | n2=en:normal or elevated lymphocytes | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:normal or increased numbers of b cells
n1=en:increased igm levels, polyclonal | n2=en:normal or increased numbers of b cells | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:partially defective antibody production
n1=en:increased igm levels, polyclonal | n2=en:partially defective antibody production | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:polymorphonuclear leukocytosis, episodic
n1=en:increased igm levels, polyclonal | n2=en:polymorphonuclear leukocytosis, episodic | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:primary combined immunodeficiency (1 patient)
n1=en:increased igm levels, polyclonal | n2=en:primary combined immunodeficiency (1 patient) | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:primary dysfunction of b-lymphocyte isotype switching and memory b-cell generation
n1=en:increased igm levels, polyclonal | n2=en:primary dysfunction of b-lymphocyte isotype switching and memory b-cell generation | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:primary immune deficiency disorder
n1=en:increased igm levels, polyclonal | n2=en:primary immune deficiency disorder | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:psychoneuroimmunology
n1=en:increased igm levels, polyclonal | n2=en:psychoneuroimmunology | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:recurrent cutaneous and systemic pyogenic infections
n1=en:increased igm levels, polyclonal | n2=en:recurrent cutaneous and systemic pyogenic infections | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:recurrent infections (pulmonary, skin, teeth)
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections (pulmonary, skin, teeth) | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:recurrent infections due to ciliary dysfunction
n1=en:increased igm levels, polyclonal | n2=en:recurrent infections due to ciliary dysfunction | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:reduced number of ct4+ t cells (in some patients)
n1=en:increased igm levels, polyclonal | n2=en:reduced number of ct4+ t cells (in some patients) | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:reduction of mature b cells
n1=en:increased igm levels, polyclonal | n2=en:reduction of mature b cells | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:variable degree of t cell dysfunction
n1=en:increased igm levels, polyclonal | n2=en:variable degree of t cell dysfunction | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 26 / 0.605 ->
en:variably decreased serum iga, igg, and igm
n1=en:increased igm levels, polyclonal | n2=en:variably decreased serum iga, igg, and igm | rel=r_associated | relid=0 | w=26
- en:increased igm levels, polyclonal --
r_associated #0: 25 / 0.581 ->
en:increased
n1=en:increased igm levels, polyclonal | n2=en:increased | rel=r_associated | relid=0 | w=25
- en:increased igm levels, polyclonal --
r_associated #0: 20 / 0.465 ->
en:allergic manifestations
n1=en:increased igm levels, polyclonal | n2=en:allergic manifestations | rel=r_associated | relid=0 | w=20
- en:increased igm levels, polyclonal --
r_associated #0: 20 / 0.465 ->
en:defects in t-cell activation and proliferation
n1=en:increased igm levels, polyclonal | n2=en:defects in t-cell activation and proliferation | rel=r_associated | relid=0 | w=20
- en:increased igm levels, polyclonal --
r_associated #0: 20 / 0.465 ->
en:extremely low or absent t cells
n1=en:increased igm levels, polyclonal | n2=en:extremely low or absent t cells | rel=r_associated | relid=0 | w=20
| ≈ 836 relations entrantes
- en:low t cells ---
r_associated #0: 40 -->
en:increased igm levels, polyclonal
n1=en:low t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=40
- en:impaired interferon production ---
r_associated #0: 38 -->
en:increased igm levels, polyclonal
n1=en:impaired interferon production | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=38
- en:increased nonspecific cd8+ t-cell proliferation ---
r_associated #0: 38 -->
en:increased igm levels, polyclonal
n1=en:increased nonspecific cd8+ t-cell proliferation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=38
- en:lack of peripheral lymphoid tissue ---
r_associated #0: 38 -->
en:increased igm levels, polyclonal
n1=en:lack of peripheral lymphoid tissue | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=38
- en:autoimmune disease resembling systemic lupus erythematosus (sle, 152700) (in about 26%) ---
r_associated #0: 35 -->
en:increased igm levels, polyclonal
n1=en:autoimmune disease resembling systemic lupus erythematosus (sle, 152700) (in about 26%) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=35
- en:autoimmunity (rare) ---
r_associated #0: 35 -->
en:increased igm levels, polyclonal
n1=en:autoimmunity (rare) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=35
- en:candida albicans infections, chronic, recurrent ---
r_associated #0: 35 -->
en:increased igm levels, polyclonal
n1=en:candida albicans infections, chronic, recurrent | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=35
- en:immunologic and autoimmune evaluation unremarkable ---
r_associated #0: 35 -->
en:increased igm levels, polyclonal
n1=en:immunologic and autoimmune evaluation unremarkable | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=35
- en:impaired production of interferon-gamma in response to mycobacterial infection ---
r_associated #0: 35 -->
en:increased igm levels, polyclonal
n1=en:impaired production of interferon-gamma in response to mycobacterial infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=35
- en:increased susceptibility to systemic infections, particularly mycobacteria, candida, and salmonella ---
r_associated #0: 35 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to systemic infections, particularly mycobacteria, candida, and salmonella | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=35
- en:bone marrow shows deficient granulopoiesis ---
r_associated #0: 34 -->
en:increased igm levels, polyclonal
n1=en:bone marrow shows deficient granulopoiesis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=34
- en:decreased lymphocyte apoptosis ---
r_associated #0: 34 -->
en:increased igm levels, polyclonal
n1=en:decreased lymphocyte apoptosis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=34
- en:defective t-cell proliferative responses ---
r_associated #0: 34 -->
en:increased igm levels, polyclonal
n1=en:defective t-cell proliferative responses | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=34
- en:t-cell lymphopenia ---
r_associated #0: 34 -->
en:increased igm levels, polyclonal
n1=en:t-cell lymphopenia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=34
- en:increased susceptibility to herpes encephalitis ---
r_associated #0: 32 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to herpes encephalitis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=32
- en:absent mucosal associated invariant t cells ---
r_associated #0: 31 -->
en:increased igm levels, polyclonal
n1=en:absent mucosal associated invariant t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=31
- en:autoinflammation ---
r_associated #0: 31 -->
en:increased igm levels, polyclonal
n1=en:autoinflammation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=31
- en:decreased b cells (family b) ---
r_associated #0: 31 -->
en:increased igm levels, polyclonal
n1=en:decreased b cells (family b) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=31
- en:increased susceptibility to certain viral infections ---
r_associated #0: 31 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to certain viral infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=31
- en:normal serologic immunoglobulin production to vaccination ---
r_associated #0: 31 -->
en:increased igm levels, polyclonal
n1=en:normal serologic immunoglobulin production to vaccination | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=31
- en:progressive loss of antibodies ---
r_associated #0: 31 -->
en:increased igm levels, polyclonal
n1=en:progressive loss of antibodies | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=31
- en:decreased alpha-beta cd8+ t cells (family b) ---
r_associated #0: 30 -->
en:increased igm levels, polyclonal
n1=en:decreased alpha-beta cd8+ t cells (family b) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=30
- en:elevated il8 (146930) ---
r_associated #0: 30 -->
en:increased igm levels, polyclonal
n1=en:elevated il8 (146930) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=30
- en:systemic lupus erythematosus (in rare mutation carriers unaffected by a hematologic malignancy) ---
r_associated #0: 30 -->
en:increased igm levels, polyclonal
n1=en:systemic lupus erythematosus (in rare mutation carriers unaffected by a hematologic malignancy) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=30
- en:b-cell lymphopenia (in some patients) ---
r_associated #0: 29 -->
en:increased igm levels, polyclonal
n1=en:b-cell lymphopenia (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=29
- en:decrease in granulocyte-specific cd16b (610665) isoform ---
r_associated #0: 29 -->
en:increased igm levels, polyclonal
n1=en:decrease in granulocyte-specific cd16b (610665) isoform | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=29
- en:increased susceptibility to candidal infections ---
r_associated #0: 29 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to candidal infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=29
- en:increased susceptibility to mycobacteria and intracellular bacteria ---
r_associated #0: 29 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to mycobacteria and intracellular bacteria | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=29
- en:susceptibility to infection with influenza a infection ---
r_associated #0: 29 -->
en:increased igm levels, polyclonal
n1=en:susceptibility to infection with influenza a infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=29
- en:allergic manifestations ---
r_associated #0: 28 -->
en:increased igm levels, polyclonal
n1=en:allergic manifestations | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=28
- en:impaired production of il17 ---
r_associated #0: 28 -->
en:increased igm levels, polyclonal
n1=en:impaired production of il17 | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=28
- en:increase in tlr2+ (603028)/tlr4- (603030) granulocytes ---
r_associated #0: 28 -->
en:increased igm levels, polyclonal
n1=en:increase in tlr2+ (603028)/tlr4- (603030) granulocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=28
- en:recurrent infections (otitis media and bacterial pneumonia) ---
r_associated #0: 28 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections (otitis media and bacterial pneumonia) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=28
- en:systemic lupus erythematosus (in some patients) ---
r_associated #0: 28 -->
en:increased igm levels, polyclonal
n1=en:systemic lupus erythematosus (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=28
- en:absent type 1 nk t cells ---
r_associated #0: 27 -->
en:increased igm levels, polyclonal
n1=en:absent type 1 nk t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=27
- en:b-cell lymphocytosis, b-cell, polyclonal ---
r_associated #0: 27 -->
en:increased igm levels, polyclonal
n1=en:b-cell lymphocytosis, b-cell, polyclonal | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=27
- en:defects in t-cell activation and proliferation ---
r_associated #0: 27 -->
en:increased igm levels, polyclonal
n1=en:defects in t-cell activation and proliferation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=27
- en:elevated il6 (147620) ---
r_associated #0: 27 -->
en:increased igm levels, polyclonal
n1=en:elevated il6 (147620) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=27
- en:granulomatous disease (in rare mutation carriers unaffected by a hematologic malignancy) ---
r_associated #0: 27 -->
en:increased igm levels, polyclonal
n1=en:granulomatous disease (in rare mutation carriers unaffected by a hematologic malignancy) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=27
- en:immune deficiency (in some patients) ---
r_associated #0: 27 -->
en:increased igm levels, polyclonal
n1=en:immune deficiency (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=27
- en:extremely low or absent t cells ---
r_associated #0: 26 -->
en:increased igm levels, polyclonal
n1=en:extremely low or absent t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=26
- en:impaired antibody production (in some patients) ---
r_associated #0: 26 -->
en:increased igm levels, polyclonal
n1=en:impaired antibody production (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=26
- en:increased susceptibility to virus (in some patients) ---
r_associated #0: 26 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to virus (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=26
- en:markedly elevated iga ---
r_associated #0: 26 -->
en:increased igm levels, polyclonal
n1=en:markedly elevated iga | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=26
- en:periodic fevers (in some patients) ---
r_associated #0: 26 -->
en:increased igm levels, polyclonal
n1=en:periodic fevers (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=26
- infection généralisée ---
r_associated #0: 25 -->
en:increased igm levels, polyclonal
n1=infection généralisée | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=25
- en:abnormal b cell function ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:abnormal b cell function | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:abnormal delayed hypersensitivity skin test ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:abnormal delayed hypersensitivity skin test | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:abnormal immunoglobulin level ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:abnormal immunoglobulin level | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:abnormal lymphocytic accumulation in non-lymphoid tissue ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:abnormal lymphocytic accumulation in non-lymphoid tissue | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:abnormal ratios of cd4+ helper t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:abnormal ratios of cd4+ helper t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:abnormality of b cell physiology ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:abnormality of b cell physiology | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:abnormality of humoral immunity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:abnormality of humoral immunity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:abnormality of t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:abnormality of t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:abnormally large monocytes with vacuoles ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:abnormally large monocytes with vacuoles | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:abscess formation in any organ ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:abscess formation in any organ | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:abscesses are 'cold,' lacking erythema, heat, and swelling ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:abscesses are 'cold,' lacking erythema, heat, and swelling | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absence of acetylcholine receptor (achr) autoantibodies ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absence of acetylcholine receptor (achr) autoantibodies | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absence of anti-thyroid antibodies ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absence of anti-thyroid antibodies | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absence of auto-antibodies to intrinsic factor or parietal cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absence of auto-antibodies to intrinsic factor or parietal cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absence of bactericidal oxidative 'respiratory burst' in phagocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absence of bactericidal oxidative 'respiratory burst' in phagocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absence of cd3+ t cells (1 family) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absence of cd3+ t cells (1 family) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absence of humoral and cellular immune response to foreign antigens ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absence of humoral and cellular immune response to foreign antigens | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absence of lymph node germinal center ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absence of lymph node germinal center | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absence of lymph nodes (in 1 patient) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absence of lymph nodes (in 1 patient) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absence of pancreatic autoantibodies ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absence of pancreatic autoantibodies | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absence of pus formation at site of infection ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absence of pus formation at site of infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent antibody production ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent antibody production | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent b lymphocytes in all organs ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent b lymphocytes in all organs | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent cd8+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent cd8+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent cellular immunity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent cellular immunity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent delayed hypersensitivity skin test ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent delayed hypersensitivity skin test | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent humoral immunity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent humoral immunity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent microvilli on the surface of peripheral blood lymphocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent microvilli on the surface of peripheral blood lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent mitogenic response ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent mitogenic response | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent mitogenic response to staphylococcus aureus cowan antigen (sac) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent mitogenic response to staphylococcus aureus cowan antigen (sac) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent natural killer cell cytotoxicity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent natural killer cell cytotoxicity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent or reduced cd3+ cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent or reduced cd3+ cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent or severely reduced numbers of b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent or severely reduced numbers of b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent or small dysplastic thymus ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent or small dysplastic thymus | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent peripheral blood b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent peripheral blood b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent peripheral blood t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent peripheral blood t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent plasma cells in all organs ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent plasma cells in all organs | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent sialyl-lewis x ligand (slex) expression ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent sialyl-lewis x ligand (slex) expression | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent specific antibody response ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent specific antibody response | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absent t lymphocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absent t lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:absolute lymphocyte count decreased ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:absolute lymphocyte count decreased | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:abundant cd4+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:abundant cd4+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:acetylcholine receptor (achr) autoantibodies are found in a subset of patients ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:acetylcholine receptor (achr) autoantibodies are found in a subset of patients | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:activated hla dr+ t cells in peripheral blood ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:activated hla dr+ t cells in peripheral blood | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:activated mononuclear phagocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:activated mononuclear phagocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:activated t-helper cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:activated t-helper cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:activation of the alternative complement pathway and depletion of complement components ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:activation of the alternative complement pathway and depletion of complement components | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:activation of the complement system ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:activation of the complement system | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:agammaglobulinemia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:agammaglobulinemia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:allergic to dogs ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:allergic to dogs | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:allergy to eggs ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:allergy to eggs | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:alpha/beta, cd4-/cd8- t cells are minimally or not increased ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:alpha/beta, cd4-/cd8- t cells are minimally or not increased | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:altered t-cell regulation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:altered t-cell regulation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:angioedema ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:angioedema | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:antibodies ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:antibodies | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:antibody-dependent cellular cytotoxicity of nk cells is unaffected ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:antibody-dependent cellular cytotoxicity of nk cells is unaffected | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:antigenically defective c8 detected ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:antigenically defective c8 detected | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:antigens ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:antigens | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:antinuclear antibody present (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:antinuclear antibody present (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:antinuclear antibody present, speckled pattern ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:antinuclear antibody present, speckled pattern | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:antinuclear autoantibodies (in some) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:antinuclear autoantibodies (in some) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:approximately 60% of patients have anti-gad65 antibodies ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:approximately 60% of patients have anti-gad65 antibodies | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:armed macrophage ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:armed macrophage | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:arrest of b cell development at very early stage ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:arrest of b cell development at very early stage | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:arthritis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:arthritis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:aspergillus infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:aspergillus infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:associated with autoantibodies to gad65 (anti-glutamic acid decarboxylase gad2, 138275) in serum and/or cerebrospinal fluid ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:associated with autoantibodies to gad65 (anti-glutamic acid decarboxylase gad2, 138275) in serum and/or cerebrospinal fluid | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:associated with autoimmune disorders (e.g., diabetes mellitus, thyroiditis, pernicious anemia, vitiligo) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:associated with autoimmune disorders (e.g., diabetes mellitus, thyroiditis, pernicious anemia, vitiligo) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:associated with autoimmune disorders (systemic lupus erythematosus 152700 and hashimoto thyroiditis 140300) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:associated with autoimmune disorders (systemic lupus erythematosus 152700 and hashimoto thyroiditis 140300) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:associated with serum autoantibodies to glra1 (glycine receptor alpha-1 subunit 138491, reported in 1 patient) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:associated with serum autoantibodies to glra1 (glycine receptor alpha-1 subunit 138491, reported in 1 patient) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:association with autoimmune diseases ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:association with autoimmune diseases | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:asthma ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:asthma | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:atopic disorders (eczema, food allergy, asthma) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:atopic disorders (eczema, food allergy, asthma) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:autoantibodies ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:autoantibodies | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:autoantibodies (anti-nuclear, anti-dsdna, anti-cardiolipin) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:autoantibodies (anti-nuclear, anti-dsdna, anti-cardiolipin) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:autoantibodies (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:autoantibodies (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:autoantibodies, transient ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:autoantibodies, transient | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:autoimmune disease (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:autoimmune disease (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:autoimmune diseases ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:autoimmune diseases | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:autoimmune disorders (i.e., itp, juvenile rheumatoid arthritis (jra), hypothyroidism, crohn disease) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:autoimmune disorders (i.e., itp, juvenile rheumatoid arthritis (jra), hypothyroidism, crohn disease) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:autoimmune disorders (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:autoimmune disorders (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:autoimmune features (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:autoimmune features (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:autoimmune neutropenia (less common) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:autoimmune neutropenia (less common) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:autoimmunity to pancreatic beta cells (rare) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:autoimmunity to pancreatic beta cells (rare) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:autoinflammation, systemic ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:autoinflammation, systemic | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:autoinflammatory disorders ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:autoinflammatory disorders | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:b and t cell defects (reported in 2 sibs) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:b and t cell defects (reported in 2 sibs) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:b cells lack surface cd19 and cd81 expression ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:b cells lack surface cd19 and cd81 expression | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:b cells lack surface cd19 expression ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:b cells lack surface cd19 expression | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:b cells lack surface cd20 expression ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:b cells lack surface cd20 expression | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:b-cell lymphocytosis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:b-cell lymphocytosis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:b-cell lymphopenia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:b-cell lymphopenia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:binucleated lymphocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:binucleated lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:biopsy shows lipid-laden macrophages ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:biopsy shows lipid-laden macrophages | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:block at the pro-b to pre-b stage of differentiation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:block at the pro-b to pre-b stage of differentiation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:block of b-cell differentiation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:block of b-cell differentiation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:bone marrow shows lymphoid hyperplasia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:bone marrow shows lymphoid hyperplasia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:burkholderia cepacia infection ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:burkholderia cepacia infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:c1q deficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:c1q deficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:c1q molecule present, but dysfunctional ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:c1q molecule present, but dysfunctional | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:c2 deficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:c2 deficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:c8 deficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:c8 deficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:cancer immunology ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:cancer immunology | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:candidiasis, chronic mucocutaneous ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:candidiasis, chronic mucocutaneous | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:cd4+ t-cell lymphopenia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:cd4+ t-cell lymphopenia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:cd4/cd8 ratio decreased ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:cd4/cd8 ratio decreased | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:cells show impaired immunologic responses to immune stimulation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:cells show impaired immunologic responses to immune stimulation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:cellular immunodeficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:cellular immunodeficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:cellular immunology ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:cellular immunology | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:childhood-onset systemic lupus erythematosus ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:childhood-onset systemic lupus erythematosus | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:chronic human papillomavirus (hpv) infection ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:chronic human papillomavirus (hpv) infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:chronic noninfectious lymphadenopathy ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:chronic noninfectious lymphadenopathy | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:chronic viral infections (1 patient) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:chronic viral infections (1 patient) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:circulating immune complexes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:circulating immune complexes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:circulating t and b cells are naive ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:circulating t and b cells are naive | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:clinical immunology ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:clinical immunology | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:combined humoral and cellular immunodeficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:combined humoral and cellular immunodeficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:combined immunodeficiency (reported in 1 patient) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:combined immunodeficiency (reported in 1 patient) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:combined variable immunodeficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:combined variable immunodeficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:combined variable immunodeficiency involving b and t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:combined variable immunodeficiency involving b and t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:complement component consumption ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:complement component consumption | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:congenital absence of thymus ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:congenital absence of thymus | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:congenital hypoplasia of thymus ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:congenital hypoplasia of thymus | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:continuous activation of the alternative complement pathway ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:continuous activation of the alternative complement pathway | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:cow milk allergy ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:cow milk allergy | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:cutaneous anergy ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:cutaneous anergy | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:cytokine defects ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:cytokine defects | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased b cell survival and tolerance ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased b cell survival and tolerance | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased cd19+ b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased cd19+ b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased cd27+ b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased cd27+ b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased cd3 complex ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased cd3 complex | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased cd3 expression on t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased cd3 expression on t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased cd3(-)cd16/15(+) natural killer cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased cd3(-)cd16/15(+) natural killer cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased cd3+ cells subset ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased cd3+ cells subset | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased cd4+ and cd3+/cd4+ lymphocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased cd4+ and cd3+/cd4+ lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased cd4+ cells subset ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased cd4+ cells subset | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased cd4+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased cd4+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased cd4+cd45ra+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased cd4+cd45ra+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased cd8+ cells subset ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased cd8+ cells subset | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased cd8+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased cd8+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased cell surface expression of mhc-i ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased cell surface expression of mhc-i | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased cellular caspase-8 levels ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased cellular caspase-8 levels | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased circulating b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased circulating b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased circulating b cells (total cd19+) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased circulating b cells (total cd19+) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased circulating cd4+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased circulating cd4+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased circulating class-switched memory b cells (cd19+cd27+igd-) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased circulating class-switched memory b cells (cd19+cd27+igd-) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased circulating naive t cells (1 family) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased circulating naive t cells (1 family) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased circulating nk cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased circulating nk cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased circulation t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased circulation t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased cytotoxic activity of cd8+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased cytotoxic activity of cd8+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased cytotoxic t cell activity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased cytotoxic t cell activity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased differentiated b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased differentiated b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased effector t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased effector t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased expression of neonatal fc receptor ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased expression of neonatal fc receptor | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased iga, plasma and secretory ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased iga, plasma and secretory | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased igm and igg2 ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased igm and igg2 | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased immunoglobulin g (igg) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased immunoglobulin g (igg) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased immunoglobulins, progressive ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased immunoglobulins, progressive | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased invariant nk t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased invariant nk t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased itk protein in lymphoid tissue ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased itk protein in lymphoid tissue | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased levels of naive t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased levels of naive t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased lymphatic tissue (tonsil, thymus, mesenteric nodes, peyer patches) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased lymphatic tissue (tonsil, thymus, mesenteric nodes, peyer patches) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased memory b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased memory b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased memory b cells (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased memory b cells (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased memory b cells, progressive ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased memory b cells, progressive | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased memory t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased memory t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased naive cd4+ and cd8+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased naive cd4+ and cd8+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased natural killer cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased natural killer cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased natural killer t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased natural killer t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased neutrophil and monocyte migration and chemotaxis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased neutrophil and monocyte migration and chemotaxis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased nk cells (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased nk cells (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased nk cells, particularly nk cell precursors ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased nk cells, particularly nk cell precursors | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased nk levels (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased nk levels (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased number of cd4+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased number of cd4+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased number of cd8+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased number of cd8+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased number of tcr alpha/beta+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased number of tcr alpha/beta+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased numbers of b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased numbers of b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased numbers of b-cell precursors seen in bone aspirate ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased numbers of b-cell precursors seen in bone aspirate | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased numbers of circulating nk cells (less than 5%) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased numbers of circulating nk cells (less than 5%) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased numbers of long-term memory cd8+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased numbers of long-term memory cd8+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased numbers of mature b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased numbers of mature b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased numbers of naive cd4+ and cd8+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased numbers of naive cd4+ and cd8+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased numbers of natural killer cells (nk) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased numbers of natural killer cells (nk) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased numbers of nk cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased numbers of nk cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased numbers of t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased numbers of t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased numbers of thymus emigrant cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased numbers of thymus emigrant cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased or absent beta-2-microglobulin ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased or absent beta-2-microglobulin | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased or absent il12r-beta-1 expression on t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased or absent il12r-beta-1 expression on t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased or absent pre-b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased or absent pre-b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased or normal numbers of nk cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased or normal numbers of nk cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased percentage of igd+ igm+ cd27+ memory b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased percentage of igd+ igm+ cd27+ memory b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased percentage of igd- igm- cd27+ class-switched memory b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased percentage of igd- igm- cd27+ class-switched memory b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased regulatory t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased regulatory t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased serum complement c3 ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased serum complement c3 | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased serum complement c3 (120700) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased serum complement c3 (120700) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased serum complement factor b (cfb, 138470) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased serum complement factor b (cfb, 138470) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased serum complement factor h (cfh, 134370) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased serum complement factor h (cfh, 134370) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased serum complement factor i ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased serum complement factor i | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased serum iga ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased serum iga | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased serum igg and igm ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased serum igg and igm | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased serum igm ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased serum igm | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased specific antibodies ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased specific antibodies | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased t cell activation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased t cell activation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased t cell production of cytokines ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased t cell production of cytokines | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased t cell proliferation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased t cell proliferation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased t cell response to mitogens ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased t cell response to mitogens | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased t cell-dependent antibody production ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased t cell-dependent antibody production | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased t-cell proliferative response to mitogens ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased t-cell proliferative response to mitogens | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:decreased t-cell proliferative responses in vitro ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:decreased t-cell proliferative responses in vitro | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defect in b-cell differentiation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defect in b-cell differentiation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defect in v(d)j recombination process ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defect in v(d)j recombination process | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective antibody production ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective antibody production | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective antibody production against polysaccharide-based vaccines ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective antibody production against polysaccharide-based vaccines | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective antibody production, particularly t-cell-independent ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective antibody production, particularly t-cell-independent | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective antibody response ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective antibody response | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective antigen-specific skin response ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective antigen-specific skin response | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective b cell activation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective b cell activation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective b cell class-switching ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective b cell class-switching | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective b cell differentiation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective b cell differentiation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective cd8+ t cell function ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective cd8+ t cell function | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective cd95-induced apoptosis of peripheral blood lymphocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective cd95-induced apoptosis of peripheral blood lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective complement regulation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective complement regulation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective generation of somatic hypermutations (shm) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective generation of somatic hypermutations (shm) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective humoral response ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective humoral response | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective il10 production by t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective il10 production by t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective il21r-related signaling ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective il21r-related signaling | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective intracellular signaling in lymphocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective intracellular signaling in lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective macrophage function ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective macrophage function | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective natural killer cell (nk) activation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective natural killer cell (nk) activation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective neutrophil adhesion to endothelial cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective neutrophil adhesion to endothelial cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective neutrophil function ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective neutrophil function | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective nk function in spontaneous cellular cytotoxicity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective nk function in spontaneous cellular cytotoxicity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective production of nfkb1-dependent cytokines by white blood cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective production of nfkb1-dependent cytokines by white blood cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective response of b and t cells to activation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective response of b and t cells to activation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:defective t cell function ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:defective t cell function | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:deficient nk-cell mediated spontaneous and antibody-mediated cytotoxicity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:deficient nk-cell mediated spontaneous and antibody-mediated cytotoxicity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:delayed wound healing with normal immune system ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:delayed wound healing with normal immune system | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:dendritic cell cytopenia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:dendritic cell cytopenia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:depleted cd4+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:depleted cd4+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:depletion of components of the alternative complement pathway ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:depletion of components of the alternative complement pathway | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:dermatomyositis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:dermatomyositis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:dermatomyositis (in 1 patient) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:dermatomyositis (in 1 patient) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:dermatophytic lymphadenitis (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:dermatophytic lymphadenitis (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:developmental arrest of b cells at the pre-b to pro-b cell transition stage ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:developmental arrest of b cells at the pre-b to pro-b cell transition stage | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:developmental immunology ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:developmental immunology | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:diminished proliferative response of t cells to allogenic cells, mitogens, and antigens ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:diminished proliferative response of t cells to allogenic cells, mitogens, and antigens | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:disseminated candidiasis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:disseminated candidiasis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:disseminated infection with dimorphic fungi (coccidioides and histoplasma) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:disseminated infection with dimorphic fungi (coccidioides and histoplasma) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:dysfunctional alternative complement pathway ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:dysfunctional alternative complement pathway | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:dysfunctional nk cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:dysfunctional nk cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:dysgammaglobulinemia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:dysgammaglobulinemia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:ectopic thymus ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:ectopic thymus | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:elevated iga (equal to or greater than 2.6g/l) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:elevated iga (equal to or greater than 2.6g/l) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:elevated igd ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:elevated igd | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:elevated immunoglobulins, particularly ige ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:elevated immunoglobulins, particularly ige | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:elevated levels of serum ige ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:elevated levels of serum ige | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:elevated polyclonal igd (equal to or greater than 100 iu/ml) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:elevated polyclonal igd (equal to or greater than 100 iu/ml) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:enterovirus infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:enterovirus infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:environmental illness ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:environmental illness | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:erythrophagocytosis in late phase ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:erythrophagocytosis in late phase | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:escherichia coli infection ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:escherichia coli infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:evidence of ebv infection ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:evidence of ebv infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:exaggerated cellular immune processes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:exaggerated cellular immune processes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:extrahepatic reticuloendothelial system spared ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:extrahepatic reticuloendothelial system spared | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:fertility immunology ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:fertility immunology | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:few mature neutrophils in the bone marrow ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:few mature neutrophils in the bone marrow | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:food allergies (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:food allergies (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:food allergy ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:food allergy | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:foot infections leading to amputation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:foot infections leading to amputation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:foot ulcer ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:foot ulcer | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:frequent bacterial, fungal and viral infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:frequent bacterial, fungal and viral infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:frequent bacterial, viral, and opportunistic infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:frequent bacterial, viral, and opportunistic infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:frequent bacterial, viral, protozoan, and fungal infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:frequent bacterial, viral, protozoan, and fungal infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:frequent fungal, viral, and opportunistic infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:frequent fungal, viral, and opportunistic infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:frequent illnesses ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:frequent illnesses | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:frequent infections in childhood ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:frequent infections in childhood | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:frequent infections t-lymphocyte dysfunction, rare ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:frequent infections t-lymphocyte dysfunction, rare | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:fulminant infectious mononucleosis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:fulminant infectious mononucleosis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:generalized enlarged lymph nodes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:generalized enlarged lymph nodes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:generalized lymphohistiocytic infiltrates in late phase ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:generalized lymphohistiocytic infiltrates in late phase | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:giant germinal centers in lymph nodes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:giant germinal centers in lymph nodes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:granulocyte dysfunction (1 patient) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:granulocyte dysfunction (1 patient) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:granuloma formation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:granuloma formation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:granulomas can appear on skin, tongue, lungs, or other tissues ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:granulomas can appear on skin, tongue, lungs, or other tissues | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:granulomas, non-infectious ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:granulomas, non-infectious | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hashimoto disease ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hashimoto disease | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hay fever ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hay fever | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hemolytic anemia (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hemolytic anemia (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hemophagocytic syndrome (hs) characterized by acute onset of uncontrolled t-lymphocyte and macrophage activation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hemophagocytic syndrome (hs) characterized by acute onset of uncontrolled t-lymphocyte and macrophage activation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hemophagocytosis (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hemophagocytosis (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hemophagocytosis in bone marrow and lymph nodes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hemophagocytosis in bone marrow and lymph nodes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hemophagocytosis in bone marrow, lymph nodes, spleen, liver, and central nervous system ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hemophagocytosis in bone marrow, lymph nodes, spleen, liver, and central nervous system | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:henoch-schoenlein purpura ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:henoch-schoenlein purpura | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:herpes simplex virus infection, mucocutaneous ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:herpes simplex virus infection, mucocutaneous | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:herpesviridae infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:herpesviridae infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:histology shows large regions of necrosis in lymph nodes, thymus, bone marrow, and spleen ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:histology shows large regions of necrosis in lymph nodes, thymus, bone marrow, and spleen | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hla antigens cw6, b13, b17 associated with psoriasis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hla antigens cw6, b13, b17 associated with psoriasis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:humoral defect (in some) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:humoral defect (in some) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:humoral deficiency (likely result of t-cell abnormalities) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:humoral deficiency (likely result of t-cell abnormalities) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hyper iga (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hyper iga (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hypereosinophilia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hypereosinophilia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hypergammaglobulinemia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hypergammaglobulinemia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hypergammaglobulinemia (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hypergammaglobulinemia (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hyperglobulinemia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hyperglobulinemia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hyperglobulinemia, polyclonal (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hyperglobulinemia, polyclonal (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hyperinflammatory disorder ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hyperinflammatory disorder | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hyperinflammatory state ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hyperinflammatory state | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hyperinflammatory state (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hyperinflammatory state (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hyperplasia of tonsils ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hyperplasia of tonsils | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hyperproliferation of effector t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hyperproliferation of effector t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hypersensitivity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hypersensitivity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hypocomplementemia (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hypocomplementemia (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hypogammaglobulinemia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hypogammaglobulinemia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hypogammaglobulinemia (1 patient) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hypogammaglobulinemia (1 patient) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hypogammaglobulinemia (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hypogammaglobulinemia (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hypogammaglobulinemia, profound ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hypogammaglobulinemia, profound | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hypoglobulinemia result ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hypoglobulinemia result | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hypoimmunoglobulinemia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hypoimmunoglobulinemia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:hypoplastic thymus which often lacks hassal corpuscles ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:hypoplastic thymus which often lacks hassal corpuscles | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:igg deficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:igg deficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:igg, decreased ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:igg, decreased | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:igm deficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:igm deficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:igm immunodeficiency (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:igm immunodeficiency (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:il6 continuously elevated (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:il6 continuously elevated (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immune defect due to a t cell deficit ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immune defect due to a t cell deficit | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immune disorder (in rare mutations carriers unaffected by a hematologic malignancy) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immune disorder (in rare mutations carriers unaffected by a hematologic malignancy) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immune dysregulation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immune dysregulation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immune response ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immune response | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immunity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immunity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immunodeficiency (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immunodeficiency (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immunodeficiency syndrome ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immunodeficiency syndrome | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immunodeficiency, primarily affecting b cell line ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immunodeficiency, primarily affecting b cell line | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immunodeficiency, severe combined (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immunodeficiency, severe combined (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immunogenetics ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immunogenetics | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immunoglobulin a decreased ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immunoglobulin a decreased | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immunoglobulin a deficiency (disorder) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immunoglobulin a deficiency (disorder) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immunoglobulin deficiency (iga, igg, igm) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immunoglobulin deficiency (iga, igg, igm) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immunohematology ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immunohematology | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immunologic evaluation unremarkable ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immunologic evaluation unremarkable | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immunology ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immunology | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immunology, other ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immunology, other | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immunophenotyping ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immunophenotyping | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immunoregulation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immunoregulation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:immunotoxicity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:immunotoxicity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired antiviral response to alpha- and beta-interferon signaling ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired antiviral response to alpha- and beta-interferon signaling | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired antiviral response to alpha-interferon signaling ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired antiviral response to alpha-interferon signaling | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired b cell class-switching ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired b cell class-switching | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired b cell memory cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired b cell memory cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired b-cell differentiation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired b-cell differentiation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired cellular and humoral immunity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired cellular and humoral immunity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired cellular responses to certain cytokine pathways ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired cellular responses to certain cytokine pathways | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired ig class switch recombination ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired ig class switch recombination | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired immune responses ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired immune responses | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired lymphocyte apoptosis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired lymphocyte apoptosis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired lymphocyte proliferation response to malignancy ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired lymphocyte proliferation response to malignancy | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired nk cell degranulation (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired nk cell degranulation (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired seroconversion of immunoglobulins in response to vaccination ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired seroconversion of immunoglobulins in response to vaccination | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired signaling through the t-cell receptor ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired signaling through the t-cell receptor | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired survival of mature t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired survival of mature t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired t cell activation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired t cell activation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired t cell function ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired t cell function | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired t cell immunity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired t cell immunity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired t cell proliferation and activation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired t cell proliferation and activation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired t cell proliferative response ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired t cell proliferative response | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:impaired t-cell proliferation to certain stimuli ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:impaired t-cell proliferation to certain stimuli | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:inability to mount antibody response to antigen ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:inability to mount antibody response to antigen | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:inability to reject allogenic cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:inability to reject allogenic cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increase in b cell number ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increase in b cell number | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increase in b cells (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increase in b cells (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increase in cd16+ activated granulocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increase in cd16+ activated granulocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increase in cd8+ t cells (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increase in cd8+ t cells (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increase in certain cytokines (il4, il5, il13, il17) upon stimulation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increase in certain cytokines (il4, il5, il13, il17) upon stimulation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increase in proinflammatory chemokines ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increase in proinflammatory chemokines | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increase in proinflammatory cytokines ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increase in proinflammatory cytokines | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased activated cd8+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased activated cd8+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased alpha-interferon activity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased alpha-interferon activity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased cd21+ (low) b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased cd21+ (low) b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased circulating transitional b cells (cd19+cd38+igm+) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased circulating transitional b cells (cd19+cd38+igm+) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased delta-gamma cd8+ t cells (family b) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased delta-gamma cd8+ t cells (family b) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased effector cd8+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased effector cd8+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased frequency of bacterial, viral, and fungal infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased frequency of bacterial, viral, and fungal infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased ig ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased ig | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased iga level ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased iga level | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased ige impaired nk cell activity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased ige impaired nk cell activity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased ige level ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased ige level | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased igm (1 patient) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased igm (1 patient) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased igm level ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased igm level | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased il6, episodic ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased il6, episodic | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased levels of t cells bearing gamma/delta antigen receptor ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased levels of t cells bearing gamma/delta antigen receptor | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased number of cd4(-)cd8(-)tcr-alpha-beta(+) t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased number of cd4(-)cd8(-)tcr-alpha-beta(+) t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased number of cd4-/cd8- t cells expressing alpha/beta t-cell receptors ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased number of cd4-/cd8- t cells expressing alpha/beta t-cell receptors | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased number of circulating lymphocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased number of circulating lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased number of peripheral cd3+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased number of peripheral cd3+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased percentage of naive b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased percentage of naive b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased percentage of naive igd+ igm+ cd27- b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased percentage of naive igd+ igm+ cd27- b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased percentage of naive t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased percentage of naive t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased proportion of cd19+ b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased proportion of cd19+ b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased proportion of hla dr+ and cd57+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased proportion of hla dr+ and cd57+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased serum ige ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased serum ige | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased serum ige (1 patient) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased serum ige (1 patient) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased serum ige, iga, igg ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased serum ige, iga, igg | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased serum igm (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased serum igm (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased susceptibility to bacterial infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to bacterial infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased susceptibility to certain bacterial infections, especially neisseria meningitidis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to certain bacterial infections, especially neisseria meningitidis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased susceptibility to ebv infection ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to ebv infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased susceptibility to haemophilus influenzae infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to haemophilus influenzae infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased susceptibility to infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased susceptibility to infections (bacterial, fungal, and viral) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to infections (bacterial, fungal, and viral) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased susceptibility to mycobacterial infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to mycobacterial infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased susceptibility to neisseria infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to neisseria infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased susceptibility to pneumocystis and cytomegalovirus infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to pneumocystis and cytomegalovirus infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased susceptibility to severe and frequent infections with staphylococcus aureus ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to severe and frequent infections with staphylococcus aureus | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased susceptibility to streptococcus pneumoniae infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased susceptibility to streptococcus pneumoniae infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased t cell activation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased t cell activation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased total number of cd19+ b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased total number of cd19+ b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:increased transitional b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:increased transitional b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:infectious disease immunology ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:infectious disease immunology | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:infectious mononucleosis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:infectious mononucleosis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:intrinsic b cell defect ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:intrinsic b cell defect | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:invasive bacterial, viral, and mycobacterial infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:invasive bacterial, viral, and mycobacterial infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:isolated absence of cd8+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:isolated absence of cd8+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:kappa-chain deficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:kappa-chain deficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:klebsiella infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:klebsiella infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lack of acquired antibodies ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lack of acquired antibodies | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lack of autoantibodies ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lack of autoantibodies | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lack of cd27 expression on lymphocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lack of cd27 expression on lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lack of circulating dendritic cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lack of circulating dendritic cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lack of circulating monocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lack of circulating monocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lack of peripheral cd3+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lack of peripheral cd3+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lack of thymus on ultrasound ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lack of thymus on ultrasound | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:leukocytosis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:leukocytosis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:leukopenia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:leukopenia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:loss of or marked reduction of v(d)j recombination activity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:loss of or marked reduction of v(d)j recombination activity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:low igg ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:low igg | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:low igg and iga ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:low igg and iga | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:low igg in adolescence (2 of 4 affected individuals) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:low igg in adolescence (2 of 4 affected individuals) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:low igg with antibody deficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:low igg with antibody deficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:low levels of antibodies to s. pneumoniae, h. influenzae type b ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:low levels of antibodies to s. pneumoniae, h. influenzae type b | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:low levels of memory b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:low levels of memory b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:low memory b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:low memory b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:low naive t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:low naive t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:low nk cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:low nk cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:low or normal serum immunoglobulins ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:low or normal serum immunoglobulins | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:low specific antibody titers (e.g., tetanus, polio virus, mumps, rubella) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:low specific antibody titers (e.g., tetanus, polio virus, mumps, rubella) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:low t-cell function ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:low t-cell function | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:low to normal immunoglobulin levels ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:low to normal immunoglobulin levels | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:low-absent igg, iga ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:low-absent igg, iga | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:low-normal iga levels ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:low-normal iga levels | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:low-to-absent igg, iga, ige ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:low-to-absent igg, iga, ige | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lupus erythematosus, systemic ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lupus erythematosus, systemic | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lupus-like syndrome (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lupus-like syndrome (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymph node architecture severely altered: lack of follicles, depletion of lymphocytes, and increased proportion of interdigitating reticular cells and eosinophils ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymph node architecture severely altered: lack of follicles, depletion of lymphocytes, and increased proportion of interdigitating reticular cells and eosinophils | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymph node hyperplasia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymph node hyperplasia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymph nodes are small and poorly developed ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymph nodes are small and poorly developed | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymph nodes show florid reactive follicular hyperplasia and marked paracortical expansion with immunoblasts and plasma cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymph nodes show florid reactive follicular hyperplasia and marked paracortical expansion with immunoblasts and plasma cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymph nodes show reactive follicular hyperplasia and non-caseating granulomas ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymph nodes show reactive follicular hyperplasia and non-caseating granulomas | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphadenitis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphadenitis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphadenitis subsequent to bcg vaccination (in 1 patient) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphadenitis subsequent to bcg vaccination (in 1 patient) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphadenopathy ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphadenopathy | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphadenopathy (cervical, inguinal, axillary) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphadenopathy (cervical, inguinal, axillary) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphadenopathy (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphadenopathy (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphadenopathy in late phase ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphadenopathy in late phase | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphadenopathy may occur ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphadenopathy may occur | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphadenopathy subsequent to bcg vaccination ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphadenopathy subsequent to bcg vaccination | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphadenopathy, generalized (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphadenopathy, generalized (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphocyte count normal ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphocyte count normal | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphohistiocytic infiltration and hemophagocytosis in multiple organs ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphohistiocytic infiltration and hemophagocytosis in multiple organs | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphohistiocytosis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphohistiocytosis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphoid depletion ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphoid depletion | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphoid hyperplasia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphoid hyperplasia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphoid hypoplasia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphoid hypoplasia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphopenia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphopenia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphopenia (1 family) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphopenia (1 family) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphopenia, progressive ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphopenia, progressive | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:lymphoproliferation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:lymphoproliferation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:marked depletion of lymphoid tissues ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:marked depletion of lymphoid tissues | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:marked reduction in cd4+/cd8+ ratio (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:marked reduction in cd4+/cd8+ ratio (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:markedly depressed t lymphocyte proportion ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:markedly depressed t lymphocyte proportion | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:markedly elevated ige ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:markedly elevated ige | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:markedly elevated ige levels ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:markedly elevated ige levels | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:markedly reduced cd3+ proportion ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:markedly reduced cd3+ proportion | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:markedly reduced neutrophil motility ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:markedly reduced neutrophil motility | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:markedly reduced numbers of natural killer cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:markedly reduced numbers of natural killer cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:markedly reduced t cell function ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:markedly reduced t cell function | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:maturational arrest of granulocytes at the promyelocyte/myelocyte stage seen on bone marrow biopsy ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:maturational arrest of granulocytes at the promyelocyte/myelocyte stage seen on bone marrow biopsy | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:microorganism immunology ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:microorganism immunology | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:mild to moderately reduced t cell count ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:mild to moderately reduced t cell count | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:mildly decreased or normal t-cell proliferative responses ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:mildly decreased or normal t-cell proliferative responses | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:mildly decreased proliferative responses of t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:mildly decreased proliferative responses of t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:moderate-low complement c3 ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:moderate-low complement c3 | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:moderately depressed antibody response to polysaccharide antigens ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:moderately depressed antibody response to polysaccharide antigens | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:moderately elevated ige ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:moderately elevated ige | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:molecular immunology ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:molecular immunology | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:monocytes show impaired motility ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:monocytes show impaired motility | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:monocytopenia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:monocytopenia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:monocytosis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:monocytosis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:mycobacterium infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:mycobacterium infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:mycoses ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:mycoses | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:myeloid proliferation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:myeloid proliferation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:natural killer cells, reduced numbers and cytotoxicity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:natural killer cells, reduced numbers and cytotoxicity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:natural killer t cell count decreased ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:natural killer t cell count decreased | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:neonatal sepsis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:neonatal sepsis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:neoplasm/cancer immunology ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:neoplasm/cancer immunology | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:neuroimmunology ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:neuroimmunology | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:neuroimmunomodulation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:neuroimmunomodulation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:neutropenia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:neutropenia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:neutropenia (in most patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:neutropenia (in most patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:neutropenia (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:neutropenia (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:neutrophils show defective intracellular nadph oxidase production ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:neutrophils show defective intracellular nadph oxidase production | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:neutrophils show disorganized lysosomal compartments on ultrastructural analysis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:neutrophils show disorganized lysosomal compartments on ultrastructural analysis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:nk cells showed unusual surface cd16 antibody reactions ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:nk cells showed unusual surface cd16 antibody reactions | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:no antibodies to intrinsic factor ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:no antibodies to intrinsic factor | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:no clinical signs of immunodeficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:no clinical signs of immunodeficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:no concurrent allergies ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:no concurrent allergies | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:no concurrent parasitic infection ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:no concurrent parasitic infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:no evidence of common prenatal infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:no evidence of common prenatal infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:no evidence of immunodeficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:no evidence of immunodeficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:no evidence of intrauterine or perinatal infection ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:no evidence of intrauterine or perinatal infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:no evidence of prenatal infection ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:no evidence of prenatal infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:no immune defects reported ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:no immune defects reported | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:no immunodeficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:no immunodeficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:no immunologic abnormalities ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:no immunologic abnormalities | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:no response to pneumococcal vaccination ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:no response to pneumococcal vaccination | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:no severe viral infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:no severe viral infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:non-caseating granulomas (bone marrow and lymph nodes) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:non-caseating granulomas (bone marrow and lymph nodes) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:non-malignant mixed lymphohistiocytic infiltration of the reticuloendothelial system ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:non-malignant mixed lymphohistiocytic infiltration of the reticuloendothelial system | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal activity of natural killer cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal activity of natural killer cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal b cell function ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal b cell function | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal b-cell (cd19+) count ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal b-cell (cd19+) count | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal b-cell count ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal b-cell count | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal cell mediated immunity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal cell mediated immunity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal igg, iga, igm, ige levels ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal igg, iga, igm, ige levels | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal immune profile ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal immune profile | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal levels of igm, iga, and igg ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal levels of igm, iga, and igg | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal nk cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal nk cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal number of b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal number of b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal number of circulating lymphocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal number of circulating lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal number of natural killer cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal number of natural killer cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal number of t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal number of t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal numbers and function of t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal numbers and function of t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal numbers of absolute b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal numbers of absolute b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal numbers of b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal numbers of b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal numbers of cd19+ b-lymphocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal numbers of cd19+ b-lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal numbers of cd56+ natural killer cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal numbers of cd56+ natural killer cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal numbers of circulating t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal numbers of circulating t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal numbers of immune cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal numbers of immune cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal numbers of lymphocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal numbers of lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal numbers of lymphocytes and nk cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal numbers of lymphocytes and nk cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal numbers of t and b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal numbers of t and b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal or decreased numbers of circulating b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal or decreased numbers of circulating b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal or elevated lymphocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal or elevated lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal or elevated number of peripheral blood b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal or elevated number of peripheral blood b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal or elevated numbers of functional natural killer cells (nk) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal or elevated numbers of functional natural killer cells (nk) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal or increased igm ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal or increased igm | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal or increased numbers of b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal or increased numbers of b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal or increased numbers of transitional b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal or increased numbers of transitional b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal or reduced numbers of b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal or reduced numbers of b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal response to bacterial antigens ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal response to bacterial antigens | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal serum immunoglobulin levels ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal serum immunoglobulin levels | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal t-cell numbers ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal t-cell numbers | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal thymus ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal thymus | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal titers to t cell-dependent vaccines ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal titers to t cell-dependent vaccines | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal to elevated igg ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal to elevated igg | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:normal-elevated igm ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:normal-elevated igm | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:nut hypersensitivity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:nut hypersensitivity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:often an infecting organism cannot be identified ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:often an infecting organism cannot be identified | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:opportunistic infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:opportunistic infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:opportunistic infections (cmv, pneumocystis, candida) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:opportunistic infections (cmv, pneumocystis, candida) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:opportunistic infections include nocardia asteroides and mycobacterium avium complex ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:opportunistic infections include nocardia asteroides and mycobacterium avium complex | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:overproduction by t lymphocytes and macrophages of cytokines, particularly interferon gamma and tumor necrosis factor alpha ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:overproduction by t lymphocytes and macrophages of cytokines, particularly interferon gamma and tumor necrosis factor alpha | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:papillomavirus infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:papillomavirus infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:partial t-cell lymphopenia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:partial t-cell lymphopenia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:partially defective antibody production ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:partially defective antibody production | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:patient cells show no gamma-interferon response to il12 ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:patient cells show no gamma-interferon response to il12 | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:paucity of lymphoid tissue ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:paucity of lymphoid tissue | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:peripheral lymphopenia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:peripheral lymphopenia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:perirectal abscess ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:perirectal abscess | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:persistent polyclonal b-cell lymphocytosis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:persistent polyclonal b-cell lymphocytosis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:polyclonal b-cell lymphocytosis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:polyclonal b-cell lymphocytosis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:polymorphic b cell lymphoproliferation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:polymorphic b cell lymphoproliferation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:polymorphonuclear leukocytosis, episodic ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:polymorphonuclear leukocytosis, episodic | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:polysaccharide antibody response defect ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:polysaccharide antibody response defect | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:poor adhesion related functions, such as adhesion to endothelial cells, chemotaxis, and antibody-dependent cellular cytotoxicity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:poor adhesion related functions, such as adhesion to endothelial cells, chemotaxis, and antibody-dependent cellular cytotoxicity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:poor antibody response ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:poor antibody response | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:poor antigen specific t-cell proliferation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:poor antigen specific t-cell proliferation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:poor differentiation and proliferation of b and t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:poor differentiation and proliferation of b and t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:poor production of certain cytokines (il-12, gamma-interferon, il-10, il-6, tnf-alpha) after stimulation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:poor production of certain cytokines (il-12, gamma-interferon, il-10, il-6, tnf-alpha) after stimulation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:poor proliferative response of t lymphocytes to specific antigens ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:poor proliferative response of t lymphocytes to specific antigens | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:poor t-cell mitogen response ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:poor t-cell mitogen response | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:positive anti-nucleus antibodies ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:positive anti-nucleus antibodies | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:positive antinuclear autoantibodies ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:positive antinuclear autoantibodies | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:post-vaccination varicella (in 1 patient) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:post-vaccination varicella (in 1 patient) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:precipitated by infection (influenza a, influenza b, mycoplasma, hhv6) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:precipitated by infection (influenza a, influenza b, mycoplasma, hhv6) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:pregnancy immunology ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:pregnancy immunology | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:presence of c3 nephritic factor autoantibody ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:presence of c3 nephritic factor autoantibody | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:present but small tonsils ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:present but small tonsils | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:primary combined immunodeficiency (1 patient) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:primary combined immunodeficiency (1 patient) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:primary dysfunction of b-lymphocyte isotype switching and memory b-cell generation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:primary dysfunction of b-lymphocyte isotype switching and memory b-cell generation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:primary immune deficiency disorder ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:primary immune deficiency disorder | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:properdin deficiency, x-linked ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:properdin deficiency, x-linked | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:pseudomonas infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:pseudomonas infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:psychoneuroimmunology ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:psychoneuroimmunology | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:qualitative abnormality of granulocyte ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:qualitative abnormality of granulocyte | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent bacterial and viral infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent bacterial and viral infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent bacterial infection ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent bacterial infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent bacterial skin infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent bacterial skin infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent bacterial, viral, and fungal infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent bacterial, viral, and fungal infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent candida infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent candida infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent candidal infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent candidal infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent cutaneous and systemic pyogenic infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent cutaneous and systemic pyogenic infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent cutaneous mycoses ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent cutaneous mycoses | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent febrile illnesses ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent febrile illnesses | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent fevers ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent fevers | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent fungal infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent fungal infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent infections (1 patient) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections (1 patient) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent infections (enteritis, otitis, and urinary infection) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections (enteritis, otitis, and urinary infection) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent infections (in severe cases) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections (in severe cases) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent infections (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent infections (increased susceptibility to mycobacterial infection after bcg immunization) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections (increased susceptibility to mycobacterial infection after bcg immunization) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent infections (pneumonia, sinusitis, fulminant varicella) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections (pneumonia, sinusitis, fulminant varicella) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent infections (pulmonary, skin, teeth) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections (pulmonary, skin, teeth) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent infections at variable sites (sinusitis, otitis media, facial cellulitis, adenitis, blepharitis, conjunctivitis, gastroenteritis) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections at variable sites (sinusitis, otitis media, facial cellulitis, adenitis, blepharitis, conjunctivitis, gastroenteritis) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent infections due to ciliary dysfunction ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections due to ciliary dysfunction | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent infections in infancy and early childhood ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections in infancy and early childhood | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent infections of mucosal surfaces ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections of mucosal surfaces | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent infections, bacterial and fungal ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections, bacterial and fungal | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent infections, bacterial, viral, fungal, myobacterial ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections, bacterial, viral, fungal, myobacterial | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent infections, particularly herpes viral ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections, particularly herpes viral | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent infections, particularly to viruses and fungi ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent infections, particularly to viruses and fungi | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent meningococcal disease ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent meningococcal disease | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent mycobacterial disease (bcg and m. tuberculosis) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent mycobacterial disease (bcg and m. tuberculosis) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent neisserial infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent neisserial infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent opportunistic infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent opportunistic infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent respiratory infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent respiratory infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent severe and invasive bacterial infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent severe and invasive bacterial infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent severe infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent severe infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent sinopulmonary infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent sinopulmonary infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent skin and respiratory infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent skin and respiratory infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent staphylococcal and gram-negative infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent staphylococcal and gram-negative infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent staphylococcus aureus infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent staphylococcus aureus infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent upper respiratory tract infection ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent upper respiratory tract infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:recurrent viral infection ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:recurrent viral infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduced cd3 t-lymphocyte counts ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduced cd3 t-lymphocyte counts | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduced cd3+, cd4+, and cd8+ t-lymphocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduced cd3+, cd4+, and cd8+ t-lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduced cd4 t-lymphocyte counts ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduced cd4 t-lymphocyte counts | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduced cd4+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduced cd4+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduced cd4+/cd8+ ratio with cd8+ predominance ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduced cd4+/cd8+ ratio with cd8+ predominance | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduced delayed hypersensitivity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduced delayed hypersensitivity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduced levels of cells with igm receptors ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduced levels of cells with igm receptors | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduced natural killer cell activity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduced natural killer cell activity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduced natural killer cell cytotoxicity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduced natural killer cell cytotoxicity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduced natural killer cell number ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduced natural killer cell number | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduced number of ct4+ t cells (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduced number of ct4+ t cells (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduced number of naive t cells (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduced number of naive t cells (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduced numbers of memory b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduced numbers of memory b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduced production of interleukin 2 by mitogen stimulated blood lymphocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduced production of interleukin 2 by mitogen stimulated blood lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduced t cell cytotoxicity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduced t cell cytotoxicity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduced/absent cd3+ t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduced/absent cd3+ t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:reduction of mature b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:reduction of mature b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:relative t-cell anergy ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:relative t-cell anergy | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:relatively increased number of natural killer cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:relatively increased number of natural killer cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:repeated invasive infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:repeated invasive infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:residual rag1 and rag2 activity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:residual rag1 and rag2 activity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:sarcoidosis (in rare mutation carriers unaffected by hematologic malignancy) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:sarcoidosis (in rare mutation carriers unaffected by hematologic malignancy) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:secondary respiratory infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:secondary respiratory infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:selective iga immunodeficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:selective iga immunodeficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:sepsis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:sepsis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:septicemia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:septicemia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:serratia marcescens infection ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:serratia marcescens infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:serum autoantibodies ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:serum autoantibodies | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:serum circulating immune complexes contain galactose-deficient iga1 ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:serum circulating immune complexes contain galactose-deficient iga1 | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:serum complement decreased ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:serum complement decreased | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:serum iga, igg, and ige severely deficient ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:serum iga, igg, and ige severely deficient | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:serum igg autoantibodies to granulocyte/macrophage colony-stimulating factor (gm-csf, csf2, 138960) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:serum igg autoantibodies to granulocyte/macrophage colony-stimulating factor (gm-csf, csf2, 138960) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:serum immunoglobulins may be absent, normal, or increased ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:serum immunoglobulins may be absent, normal, or increased | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:severe b lymphocytopenia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:severe b lymphocytopenia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:severe combined immunodeficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:severe combined immunodeficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:severe enteroviral infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:severe enteroviral infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:severe viral infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:severe viral infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:severely reduced proliferative response to mitogens, antigens, and alloantigens ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:severely reduced proliferative response to mitogens, antigens, and alloantigens | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:severely reduced response to candida and tetanus toxoid antigens ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:severely reduced response to candida and tetanus toxoid antigens | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:severely reduced response to mitogens ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:severely reduced response to mitogens | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:sjogren's syndrome ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:sjogren's syndrome | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:skin anergy to recall antigens ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:skin anergy to recall antigens | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:slightly reduced neutrophil adherence ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:slightly reduced neutrophil adherence | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:small lymph nodes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:small lymph nodes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:small lymph nodes, which lack paracortical regions ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:small lymph nodes, which lack paracortical regions | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:small or absent thymus, which contains poorly formed hassal corpuscles ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:small or absent thymus, which contains poorly formed hassal corpuscles | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:small thymus ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:small thymus | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:some patients may have autoantibodies to factor h, resulting in functional factor h deficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:some patients may have autoantibodies to factor h, resulting in functional factor h deficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:specific antibody production very poor ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:specific antibody production very poor | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:staphylococcus aureus infection ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:staphylococcus aureus infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:susceptibility to bacterial infections due to poor skin integrity ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:susceptibility to bacterial infections due to poor skin integrity | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:susceptibility to chickenpox ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:susceptibility to chickenpox | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:susceptibility to ebv and cmv infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:susceptibility to ebv and cmv infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:susceptibility to infection by mycobacterium leprae causing leprosy ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:susceptibility to infection by mycobacterium leprae causing leprosy | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:susceptibility to infection with human herpesvirus ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:susceptibility to infection with human herpesvirus | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:susceptibility to infections ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:susceptibility to infections | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:susceptibility to mycobacterial disease ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:susceptibility to mycobacterial disease | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:susceptible to vaccine-induced polio ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:susceptible to vaccine-induced polio | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:systemic inflammatory response (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:systemic inflammatory response (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:t cell defect, mild to severe ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:t cell defect, mild to severe | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:t cells may show impaired proliferative response to tetanus toxoid ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:t cells may show impaired proliferative response to tetanus toxoid | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:t regulatory cells show poor function ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:t regulatory cells show poor function | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:t-cell dysfunction (1 patient) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:t-cell dysfunction (1 patient) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:t-cell dysfunction, variable (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:t-cell dysfunction, variable (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:t-cell hyporesponsiveness (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:t-cell hyporesponsiveness (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:t-cells show reduced cytotoxicity and reduced cytolytic granule exocytosis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:t-cells show reduced cytotoxicity and reduced cytolytic granule exocytosis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:t-lymphocyte deficiency ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:t-lymphocyte deficiency | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:t-lymphocytopenia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:t-lymphocytopenia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:thrombocytopenia (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:thrombocytopenia (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:thymic hypoplasia or aplasia ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:thymic hypoplasia or aplasia | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:thymoma ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:thymoma | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:thymus hypoplasia (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:thymus hypoplasia (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:thyroid hormone deficiency (1 patient) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:thyroid hormone deficiency (1 patient) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:tissue biopsy shows granulomas ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:tissue biopsy shows granulomas | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:tnf continuously elevated (in some patients) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:tnf continuously elevated (in some patients) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:transient iga deficiency (1 patient) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:transient iga deficiency (1 patient) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:transplantation immunology ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:transplantation immunology | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:undetectable igm and iga ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:undetectable igm and iga | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:undetectable/absent peripheral lymph nodes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:undetectable/absent peripheral lymph nodes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:upregulation of alpha-interferon-stimulated genes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:upregulation of alpha-interferon-stimulated genes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:usually precipitated by viral infection (influenza a, influenza b, parainfluenza ii, and mycoplasma pneumoniae) ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:usually precipitated by viral infection (influenza a, influenza b, parainfluenza ii, and mycoplasma pneumoniae) | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:vacuolated lymphocytes ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:vacuolated lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:variable (often increased) number of activated cd45ro+, dr+ circulating t cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:variable (often increased) number of activated cd45ro+, dr+ circulating t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:variable antibody response to vaccination ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:variable antibody response to vaccination | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:variable autoimmune disorders ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:variable autoimmune disorders | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:variable deficit of tissue macrophages ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:variable deficit of tissue macrophages | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:variable degree of t cell dysfunction ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:variable degree of t cell dysfunction | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:variably decreased serum iga, igg, and igm ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:variably decreased serum iga, igg, and igm | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:variably impaired t-cell proliferative responses ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:variably impaired t-cell proliferative responses | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:varicella zoster infection ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:varicella zoster infection | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:vasculitis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:vasculitis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:very low b cells ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:very low b cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:very low lymphocyte proliferation in response to mitogens and alloantigens ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:very low lymphocyte proliferation in response to mitogens and alloantigens | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- en:vitiligo ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=en:vitiligo | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- neuro-immunomodulation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=neuro-immunomodulation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- neuroimmunomodulation ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=neuroimmunomodulation | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- sepsis ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=sepsis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- vitiligo ---
r_associated #0: 20 -->
en:increased igm levels, polyclonal
n1=vitiligo | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
- absence de production d'anticorps ---
r_associated #0: 15 -->
en:increased igm levels, polyclonal
n1=absence de production d'anticorps | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=15
- absence de réponse spécifique d'anticorps ---
r_associated #0: 15 -->
en:increased igm levels, polyclonal
n1=absence de réponse spécifique d'anticorps | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=15
- asthme ---
r_associated #0: 10 -->
en:increased igm levels, polyclonal
n1=asthme | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=10
- cytotoxicité absente des cellules tueuses naturelles ---
r_associated #0: 10 -->
en:increased igm levels, polyclonal
n1=cytotoxicité absente des cellules tueuses naturelles | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=10
- infection systémique ---
r_associated #0: 10 -->
en:increased igm levels, polyclonal
n1=infection systémique | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=10
- leucopénie ---
r_associated #0: 10 -->
en:increased igm levels, polyclonal
n1=leucopénie | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=10
- mycoses ---
r_associated #0: 10 -->
en:increased igm levels, polyclonal
n1=mycoses | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=10
- rhume des foins ---
r_associated #0: 10 -->
en:increased igm levels, polyclonal
n1=rhume des foins | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=10
- susceptibilité accrue à l'encéphalite herpétique ---
r_associated #0: 10 -->
en:increased igm levels, polyclonal
n1=susceptibilité accrue à l'encéphalite herpétique | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=10
- thymome ---
r_associated #0: 10 -->
en:increased igm levels, polyclonal
n1=thymome | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=10
- vascularite ---
r_associated #0: 10 -->
en:increased igm levels, polyclonal
n1=vascularite | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=10
- vasculitis ---
r_associated #0: 10 -->
en:increased igm levels, polyclonal
n1=vasculitis | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=10
- absence d'expression de CD27 sur les lymphocytes ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=absence d'expression de CD27 sur les lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- absence de cellules B dans le sang périphérique ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=absence de cellules B dans le sang périphérique | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- absence de cellules T dans le sang périphérique ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=absence de cellules T dans le sang périphérique | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- absence de lymphocytes B dans tous les organes ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=absence de lymphocytes B dans tous les organes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- absence de lymphocytes T ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=absence de lymphocytes T | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- absence de microvillosités à la surface des lymphocytes du sang périphérique ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=absence de microvillosités à la surface des lymphocytes du sang périphérique | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- apoptose altérée des lymphocytes ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=apoptose altérée des lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- apoptose défectueuse induite par CD95 des lymphocytes du sang périphérique ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=apoptose défectueuse induite par CD95 des lymphocytes du sang périphérique | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- arthrite ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=arthrite | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- augmentation du nombre de lymphocytes circulants ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=augmentation du nombre de lymphocytes circulants | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- cellules T HLA DR+ activées dans le sang périphérique ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=cellules T HLA DR+ activées dans le sang périphérique | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- diminution de l'apoptose des lymphocytes ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=diminution de l'apoptose des lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- diminution de la numération lymphocytaire absolue ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=diminution de la numération lymphocytaire absolue | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- dysfonctionnement primaire de la commutation isotypique des lymphocytes B et de la génération de cellules B mémoires ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=dysfonctionnement primaire de la commutation isotypique des lymphocytes B et de la génération de cellules B mémoires | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- déficience en lymphocytes T ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=déficience en lymphocytes T | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- faible réponse proliférative des lymphocytes T aux antigènes spécifiques ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=faible réponse proliférative des lymphocytes T aux antigènes spécifiques | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- hypogammaglobulinémie ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=hypogammaglobulinémie | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- lymphocytes binucléés ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=lymphocytes binucléés | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- lymphocytes normaux ou élevés ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=lymphocytes normaux ou élevés | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- nombre normal de lymphocytes circulants ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=nombre normal de lymphocytes circulants | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- nombres normaux de lymphocytes ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=nombres normaux de lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- nombres normaux de lymphocytes B CD19+ ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=nombres normaux de lymphocytes B CD19+ | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- nombres normaux de lymphocytes et de cellules NK ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=nombres normaux de lymphocytes et de cellules NK | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- proportion de lymphocytes T fortement diminuée ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=proportion de lymphocytes T fortement diminuée | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- réduction de la numération des lymphocytes T CD3 ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=réduction de la numération des lymphocytes T CD3 | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- réduction de la numération des lymphocytes T CD4 ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=réduction de la numération des lymphocytes T CD4 | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- réduction de la production d'interleukine 2 par les lymphocytes sanguins stimulés par des mitogènes ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=réduction de la production d'interleukine 2 par les lymphocytes sanguins stimulés par des mitogènes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- réponse proliférative altérée des lymphocytes à la malignité ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=réponse proliférative altérée des lymphocytes à la malignité | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- septicémie du nouveau-né ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=septicémie du nouveau-né | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- septicémie néonatale ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=septicémie néonatale | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- signalisation intracellulaire défectueuse dans les lymphocytes ---
r_associated #0: 5 -->
en:increased igm levels, polyclonal
n1=signalisation intracellulaire défectueuse dans les lymphocytes | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=5
- % production ---
r_associated #0: -5 -->
en:increased igm levels, polyclonal
n1=% production | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=-5
|